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The adenovirus (Ad) ElB 55-k.Da protein is vital to viral growth and complete 
transformation of adenovirus-infected cells. The detailed mechanisms of E 1 B action are 
not yet clear. ln order to shed light on the functions of this viral oncoprotein it is 
essential to determine its cellular targets. The yeast two-hybrid method was utilized to 
screen the Saccharomyces cerevisiae genomic library and the human Hela cONA library 
with the Ad2 ElB 55-kDa protein as hait. Partial screening of the S. cerevisiae genomic 
library (106 transformants) has revealed several yeast proteins that bind to El B. Among 
these are: UFOl, involved in the ubiquitin fusion degradation pathway, a major pathway 
for selective protein degradation in eukaryotes, RIS 1, a member of the S Wl/SNF2 family 
of DNA-dependent ATPases, and Bdt2 which contains two copies of the evolutionarily 
conserved bromodomain, homologous to the C-terminal half of mammalian T Af 11250. 
Human proteins positive for Ad2 ElB 55-k.Da binding were identified through partial 
screening of the Hela cONA library (7 x 105 transformants). Among them are: UbcH7, a 
ubiquitin-conjugating enzyme involved in the ubiquitin-mediated degradation of the 
tumor suppressor protein p53, known to be stabilized and inactivated by Ad ElB 55-kDa. 
SUM0-1, a ubiquitin-like protein which covalently modifies a limited number of proteins 
in a manner similar to ubiquitination, ubiquitin itself, and DAXX, implicated in Fas-
induced apoptosis . 
The identification of a OAXX/Ad ElB 55-kDa interaction has interesting 
implications for the role of E 1 B in cell transformation. The pro-apoptotic ability of 
DAXX appears to be dependent on the physical interaction of OAXX with a tumor 
suppressor protein, PML. The binding of OAXX by PML results in the localization of 
DAXX to nuclear bodies, known as PML oncogenic domains (POOs). Ad ElB 55-k.Da 
binds to the C-terminus of OAXX, required for PML-binding and POO localization. 
Immunofluorescence co-localization experiments establish that in cell lines expressing 
Ad ElB 55-kDa proteins there is disruption of PML-DAXX association. There is also 
disruption of POO formation in these cells. These observations suggest that another 
mechanism by which the Ad ElB 55-k.Da protein contributes to cell transformation may 
be by interfering with an apoptotic pathway that acts through OAXX .. 





La protéine d'adénovirus (Ad) ElB 55-kDa est essentielle à la croissance virale et 
à la transformation complète des cellules infectées par adénovirus. Les mécanismes 
détaillés de l'action d'ElB ne sont pas encore bien connus. Afin déterminer les fonctions 
de cette oncoprotéine virale, il est essentiel de déterminer ses cibles cellulaires. La 
méthode de deux-hybride de levure a été utilisée pour cribler la bibliothèque genomique 
de Saccharomyces cerevisiae et la bibliothèque d' ADNc Hela humaine avec la protéine 
d'Ad2 ElB 55-kDa. Le criblage partiel de la bibliothèque genomique de S. cerevisiae 
(106 transformants) a indiqué plusieurs protéines de levure qui se lient à ElB. Parmi 
elles: UFD l, impliqué dans la voie de dégradation de fusion par ubiquitination, une voie 
importante pour la dégradation sélective des protéines dans les eukaryotes, RIS 1, une 
membre de la famille SWI/SNF2 d' ADN-dépendente ATPases, et Bdf2 qui contient deux 
copies du bromodomaine, domaine hautement conservé durant l'évolution et qui est 
homologue à la moitié C-terminale de TAFII250 de mammifères. Un criblage partiel de 
la bibliothèque d' ADNc de Hela humaine (7 x 105 transformants) a permis d'identifier 
des protéines humaines positives pour l'association avec Ad2 El B 55-kDa. UbcH7 est 
l'une d'entre elles. UbcH7 est une enzyme d'ubiquitination-conjugaison, impliquée dans 
la dégradation du suppresseur de tumeur p53, celui-ci reconnu pour être stabilisé et 
inactivé par Ad ElB 55-k.Da. Il y a aussi ubiquitine elle-même, SUM0-1, une protéine 
semblable aux protéines d'ubiquitination, qui modifie d'un nombre limité de protéines 
par un procédé similaire à l'ubiquitination, et DAXX, impliquée dans l'apoptose induite 
par Fas. 
L'identification d'une interaction entre DAXX et Ad E 1 B 55-kDa propose des 
implications intéressantes pour le rôle d'E l B dans la transformation de cellules. Les 
capacités pro-apoptotiques de DAXX semblent dépendre de l'interaction physique de 
DAXX avec une suppresseur de tumeur, PML. La liaison de DAXX par PML provoque 
la localisation de DAXX dans des corps nucléaires, connus sous le nom de domaines 
oncogènes de PML (PODs). La liaison d'Ad ElB 55-kDa à la portion C-terminale de 
DAXX est requise pour la liaison a PML et la localisation dans les PODs. Les 
expériences de co-localisation par immunofluorescence ont démontré que dans des 
lignées de cellulaires exprimant les protéines Ad ElB 55-k.Da il y a dissociation du 
complexe PML-DAXX. La formation des PODs dans ces cellules est aussi perturbée. 
Ces observations suggèrent un autre mécanisme par lequel la protéine d'Ad E 18 55-kDa 
contribuerait à la transformation cellulaire: celles-ci pour interférer avec un processus 
apoptotique qui agit par l'intermédiaire de DAXX. 
Mots clés: adénovirus, EIB 55-kDa, oncoprotéine, deux-hybride de levure, DA.XX 
Introduction 
General Background on Adenoviruses 
Adenoviruses (Ad) are a broad family of viroses with double-stranded 
DNA genomes of -35 kilo base pairs (kb). There are greater than 40 adenovirus 
serotypes classified into subgroups based on their percentage of G + C in DNA, 
hemaglutination properties, and tumorigenicity (listed in table 1 ). Adenovirus infections 
are quite common although most are asymptomatic. They have been associated with 
respiratory illness, conjunctivitis, and gastroenteritis in children. Adenoviruses are lytic 
in their natural host but are included within a heterogeneous group ofDNA tumor viruses 
for their ability to induce tumors in experimental systems. Other DNA tumor virus 
families include hepatitis B viruses, simian virus 40 (SV40) and polyomavirus, 
papillomaviruses, herpesviruses, and poxviruses. These are listed in table 2 along with 
their associated cancers. Certain DNA tumor viruses have been directly implicated in 
human malignancies, such as human papillomavirus type 16 (HPV-16) and HPV-18, the 
causative agents of cervical cancer and other anogenital cancers. Like adenoviruses, 
polyomavirus and SV40 are not natural transforming agents. However, these viruses are 
useful for studying the transformation process. The first report of a pathogenic human 
virus that could cause cancer in animais was the discovery that adenovirus type 12 could 
induce malignant tumor formation in rodents (Trentin et al., 1962). This sparked 
extensive study into the mechanisms of transformation by adenoviruses and other viruses. 





viruses and cancer bas led to the identification of different cellular tumor suppressors, 
contributing to the understanding of human cancer development. 
Table 1: DNA tumor viruses and associated cancers. 
VIRUS F AMIL Y ASSOCIA TED CANCERS 
Hepadnaviruses Hepatocellular carcinoma 
Polyomaviruses V arious solid tumors 
Papillomaviruses Papillomas and carcinomas 
Adenoviruses V arious solid tumors 
Herpesviruses Lymphomas and carcinomas 
Poxviruses Mixomas and fibromas 
Modifiedfrom: T. Benjamin and P. K. Vogt. 1991. Cel! transformation 
by viruses. ln: B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, 
J. L. Melnick, T. P. Monath, and B. Roizman, eds. Fundamental 
Virology, second edition. New York: Raven Press 291-341 
• • • 
Table 2: Classification se hem es for human adenovirus. 
ONCOGENIC POTENTIAL 
SUBGROUP HEMAGLUTINATION SEROTYPES PERCENT AGE GROUPS Tumours in Transformation OFG+C IN DNA 
animais in tissue culture 
A IV 12, 18, 31 High + 48-49 
B 3, 7, 11, 14, 16, Moderate + 50-52 21, 34, 35 
c III 1,2,5,6 Low or none + 57-59 
8, 9, 19, 37, 10, 
D Il 13, 15, 17, 19,20, Lowornone + 57-61 22-30, 32, 33, 36-
39,42 
E III 4 Lowornone + 57-59 
F III 40,41 Unknown 
Modified.from: M. S. Horwitz. 1991. Adenoviridae and their replication. /11: B. N. Fields, D. M. Knipe, R. M. 
Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman, eds. Fundamental Virology, second edition. 
New York: Raven Press 291-341 
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Adenovirus-Induced Cell Transformation 
Normal cells maintain strict control of cell growth and differentiation, 
govemed by the requirements of the organism. ln response to adverse stimuli, such as 
environmental stress, DNA damage, and viral infection, the products of tumor suppressor 
genes can signal growth arrest or programmed cell death. In contrast, transformed, 
immortalized cells undergo continuous, unregulated growth. Ali adenovirus serotypes 
are capable of transforming cells in tissue culture. The transforming genes of 
adenoviruses, like other DNA tumor viruses, are uniquely viral. Cellular equivalents of 
these genes do not exist, in contrast to retroviruses, the only RNA viruses with oncogenic 
potential, which either integrate near a cellular oncogene or carry one in their genomes. 
Adenovirus oncogenes are expressed early, prior to the onset of viral DNA replication. 
They encode proteins that interfere with the actions of cellular tumor suppressor proteins 
and at various points in signaling pathways of apoptosis. This results in the deregulation 
of cell growth control. 
Proteios lnvolved in Adeoovirus-Mediated Cell Transformation 
Complete transformation by adenoviruses requires the early region El that 
covers two transcription blocks, ElA and ElB (figure 1). ElA proteins (overlapping 
proteins of 26- and 32-kDa) force cells to enter S phase by targeting the retinoblastoma 





prevents viral-induced apoptosis. The oncoprotein that is the focus of this research is the 
large adenovirus ElB protein. The ElB 55-kDa protein inhibits the normal biological 
functions of p53 (Marcellus et al., 1996; Steegena et al., 1995; Yew and Berk, 1992). 
Figure 2 illustrates the functional domains of ElB 55-kDa including the p53 binding 
domain. Other viral oncoproteins that interfere with p53 functions include the SV40 
large T antigen (Farmer et al., 1992) and E6 of hurnan papillomavirus (Scheffner et al., 
1990). p53 is a potent turnor suppressor found mutated in more than 50% of human 
cancers. ln response to various stimuli, p53 up-regulates genes involved in growth 
suppression at G l and 02. A major component that contributes to p53-induced cell cycle 
arrest is p2 l, a cyclin-dependent kinase (CDK) inhibitor. lnhibiting CDK prevents pRb 
phosphorylation and leads to growth arrest at the G 1 /S boundary. p53 can also promo te 
apoptosis by up-regulating proteins such as Bax. The ElB 55-kDa protein associates 
with p53 and interferes with p53 transactivation of its target genes (Sarnow et al., 1982; 
Yew and Berk, 1992). lt may inhibit p53 function by more than one mechanism. First, 
the carboxyl-terminal region of EIB 55-kDa seems to act as a direct transcriptional 
repressor that could be coupled to p53 (Martin and Berk, 1998). Second, ElB 55-kDa 
specifically inhibits acetylation of p53 by P/CAF at lysine 320 (Liu et al., 2000). P/CAF 
acetylation of the p53 C-terminus stimulates its sequence-specific DNA-binding ability 
(Gu and Roeder, 1997) . 
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Figure 1: Ad2 genomic map of the early proteins and their mRNAs. 





Thin lines indicate mRNAs detected at early times post-infection in the absence of protein synthesis. Thick lines represent 
intermediate mRNAs most easily detected at late times. Arrowheads show the 3' end. Tentative promoter sites are indicated 
by [-. From: M. S. Horwitz. 1991. Adenoviridae and their replication. ln: B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. 










Figure 2: Schematic diagram illustrating the functional domains in the Ad EIB 55-kDa protein. 
E 1 B 55-kDa consists of 495 amino acids, represented ahove. Black rectangles represent known functional 




Acknowledging the contnbution of p53 inactivation to adenovirus-
mediated cellular transformation, there is evidence that points towards mechanisms of 
E 18 55-kDa action that do not involve p53. This includes experiments performed by 
Goodrum and Omelles (1997; 1998) with Ad5 ElB 55-k.Da mutants. The presence or 
absence of p53 did not predict the ability of the cell line to support growth of the EIB 55-
kDa mutant virus. In the absence of a correlation between mutant virus replication and 
p53 status, it is possible that there are other cellular regulatory factors that promote virus 
replication in the wild type adenovirus infection. Additionally, expression of the tumor 
suppressor protein, PML, inhibits Ad5 ElA/ElB-mediated focus formation of primary rat 
cells suggesting that modulation of PML activity plays a role in viral transformation 
(Nevels et al., 1999). 
Research Objectives 
The major objective of this research is to identify cellular proteins that bind to Ad 
ElB 55-k.Da. If we take examples from other DNA tumor viroses, we see that their 
oncoproteins are multifunctional but contain no intrinsic enzyme activity. The~e proteins 
exert their effects through binding to numerous cellular proteins. ElB 55-kDa is also a 
multifunctional protein. Aside from the role that ElB 55-kDa plays in the transformation 
process, it plays an important role in viral growth. EIB 55-kDa mutations that result in 
its instability hinder viral DNA synthesis (Mak and Mak, 1990). It is also required for 
the selective transport of viral mRNA from the nucleus to the cytoplasm (Leppard and 
9 
Shenk, 1989). Late viral mRNAs are differentially exported by a protein complex that 
includes ElB 55-kDa and E4orf6. It has been suggested that the viral RNA transporter of 
this complex is E4orf6 (Dobbelstein et al., 1997). Recently, however, it has been shown 
that ElB 55-kDa itself is a good candidate for an adenoviral transponer. It actively 
shuttles in virus-infected cells (Dosch et al., 2001 ), with a C-terminal nuclear localization 
signal (NLS) as well as a N-terminal leucine-rich nuclear export signal (NES) (Kratzer et 
al., 2000), as first suggested by Liao et al. (1999). ElB 55-k.Da also has RNA-binding 
activity. It contains a domain at residues 249-288 homologous to the RNP domains that 
mediate direct interaction with RNA (Horridge and Leppard, 1998). It is clear that E 1 B 
55-kDa plays many rotes in viral replication; however, the detailed mechanisms of its 
action are not yet fully understood. 
With ail of the knowledge that has accumulated on adenoviruses, surprisingly few 
EIB 55-kDa cellular targets have been identified. Recent reports on associating proteins 
include PCAF (Liu et al., 2000), and histone deacetylase (HDAC) 1 (Punga and 
Akusjarvi, 2000). lf its binding partners are resolved, this could lead to elucidation of the 
functions of ElB 55-kDa. The intended focus is EIB-binding proteins involved in cell 
cycle regulation or apoptosis in order to investigate ElB 55-kDa acti~n in cell 
transformation. Determining how the targeting of cellular proteins by ElB 55-kDa 
contributes to transformation by adenovirus may provide new directions for 






The yeast two-hybrid method was employed to find Ad ElB 55-kDa interacting 
proteins. With the use of the two-hybrid method, expression libraries can be screened for 
interaction with a protein of interest, as illustrated in figure 3. The two-hybrid method is 
a sensitive means of detecting protein-protein interactions, measured by the re-assembly 
of a functional transcription factor in yeast, which in this case is Ga14. The Gal4 DNA-
binding domain (BD) is separated from the Gal4 transcription activation domain (AD) 
and each can be fused to a protein. The BD recognizes specific upstream activating 
sequences (UAS) in the promoter of Gal4 target genes. white the AD stimulates 
transcription initiation from the UAS by directing the assembly of the transcription 
complex. For this particular screen, Ad2 E 1 B 55-kDa is fused to the Gal4 BD and this is 
referred to as the hait hybrid. A protein encoded by a library insert from either the 
Saccharomyces cerevisiae genomic library or the human Hela cDNA library is fused to 
the Gal4 AD and this is referred to as the prey hybrid. If EIB 55-kDa binds to a library 
protein, the Gal4 BD and AD are brought into close proximity and functional Gal4 is 
generated. This leads to transcription of reporter genes downstream of the UAS. If the 
two proteins do not interact then the reporter genes are not transcribed. ln the host yeast 
strain utilized there exist three reporter genes: his3, ade2, and lacZ. This allows for 
nutritional selection (his3, ade2) as well as color based assays (lacZ). A different Gal4 
promoter drives each reporter gene. The his3 reporter provides the highest sensitivity for 
growth selection and the ade2 promoter is the most stringent. The numbers of false 
11 
positives are greatly reduced with this host strain when compared to earlier strains 
containing a single promoter element (James et al., 1996). 
After determining which cellular proteins associate with Ad ElB 55-kDa through 
library screening, these interactions can then be verified by alternative means such as 
immunoprecipitation, GST pull down and immunofluorescence co-localization 
experiments. The yeast two-hybrid method can be employed to map the domains 
responsible for the interactions and identify possible E lB-binding domains. Further 
experiments can then be performed to determine whether El B 55-kDa interferes with the 
cellular functions of each positive protein. For example, ElB-binding may prevent the 
protein from interacting with other cellular proteins or block domains required for its 
activity or cellular targeting. Approaches to studying biological significance would be 


















Figure 3: Scheme of the yeast two-hybrid system used for library screening. 
Bait: Ad2 ElB 55-kDa fused to the Gal4 DNA-binding domain (BD). Prey: human HeLa 
cDNA or S. cerevisiae genomic DNA library protein (protein X) fused to the Gal4 
activation domain (AD). In the absence of an interaction between Ad2 ElB 55-kDa and 




If the human adenovirus oncoprotein does behave as oncoproteins of other 
DNA tumor viruses, then screening the Hela cDNA library with ElB 55-kDa as bait 
should yield a large number of interacting proteins. These proteins are expected to be 
involved in nucleocytoplasmic transport, transcription, and cell cycle regulation. A 
drawback to screening the Hela cDNA library is the amount of false positives that would 
be encountered. False positives would consist of human proteins associating with either 
the Gal4 UAS or the Gal4 BD irrespective of the presence of ElB 55-kDa. Performing 
the same yeast two-hybrid screen with the S. cerevisiae genomic library should not yield 
as many true or false positives. Screening the S. cerevisiae library with the Ad2 ElB 55-
kDa protein is appropriate because we know that it is biologically active in yeast. 
T nduced expression of the E 1 B protein fused to a NLS in S. cerevisiae cells inhibits cell 
growth (Liang et al., 1995). NLS-EIB is localized to the yeast nucleus and leads to 
accumulation of nuclear poly(A)+ RNA. It is expected that screening the S cerevisiae 
genomic library will reveal possible human proteins that will bind to ElB 55-kDa. 
Human proteins containing the same evolutionarily conserved domains of the yeast 
proteins or functional human homologues may also interact with El~ 55-kDa. 
Simultaneously screening both the Hela cDNA library and the S. cerevisiae genomic 
library increases the opportunity of finding hwnan ElB 55-kDa interacting proteins. 
We also expect that screening expression libraries with an ElB 55-kDa 
fragment of hwnan Ad2 may further our understanding of the effects of EIB 55-kDa of 
14 
highly oncogenic Adl2. Proteins positive for Ad2 ElB 55-kDa binding would also be 
tested for binding to Adl2 ElB 55-kDa. which proved too toxic for the host yeast to be 
used as bait. Expressing Adl2 EIB 55-kDa had a detrimental effect on yeast doubling 
time. Most of the knowledge that has accumulated on the large ElB protein has corne 
from studies with non-oncogenic Ad2 or Ad5 of the same subgroup. There is strong 
sequence similarity between the ElB 55-kDa proteins of serotypes 12 and 2/5, with the 
greatest differences in the N-terminal third. Downregulation of MCH class l by ElA 
proteins of Adl2 but not Ad2 or Ad5 is believed to play a role in Adl2 oncogenic 
potential in rodents (Pereira et al., 1995; Schouten et al., 1995). 
Introduction to Some ElB-binding Proteins Identified 
Screening the Hela cDNA library and the S. cerevisiae genomic library 
identified several ElB 55-kDa-interacting proteins. These include proteins involved in 
the ubiquitin (Ub) fusion degradation pathway, a major pathway for selective protein 
degradation in eukaryotes, such as Ub and UbcH7 from the human library and yeast 
Ufdl. Post-translational conjugation to Ub marks a protein for degradati,on by the 
proteasome. UbcH7 is a Ub-conjugating enzyme responsible for Ub-mediated 
degradation of p53 (Ciechanover, et al., 1994) and c-fos (Stancovski et al., 1995) and 
processing of the NficB (nuclear factor-KB) precursor p105 (Orian et al., 1995). Ufdl is 
involved at a post-ubiquitination step of the Ub-proteasome pathway and is highly 
conserved from yeast to humans (Johnson, et al., 1995; Novelli et al., 1998). SUM0-1 
15 
[also called UBL 1 (Shen et al., 1996), PIC l (Boddy et al., 1996), GMP l (Matunis et al., 
1996) or sentrin (Okura et al., 1996)] was also found as a result of Hela cDNA library 
screening to interact with Ad2 ElB 55-kDa. SUM0-1 is a Ub-like protein which 
covalently modifies a limited number of proteins in a manner similar to ubiquitination 
(Kamitani et al., 1997). During the process of writing this work it was discovered by 
Endter et al. (2001) that Ad5 ElB 55-kDa could be modified by SUM0-1 in vivo. 
Other interesting proteins identified include yeast Bdt2, functionally redundant 
with Bdfl and homologous to the carboxyl-terminal half of mammalian T AFn250, the 
largest subunit of TFIID (Matangkasombut et al., 2000). Bdfl, Bdt2, and T AFu250 each 
contain two copies of the evolutionarily conserved bromodomain. There is also human 
Clk l which phosphorylates SR proteins and may play a role in the altered splicing 
patterns during the switch from early to late phase of adenovirus replication (Duncan et 
al., 1997), and transcription repressor DAXX, implicated in Fas-induced apoptosis (Yang 
et al., 1997; Torii et al., 1999). The discovery that human DAXX binds to Ad2 ElB 55-
kDa inspired further investigation into the nature of this interaction. The fact that DAXX 
is suspected to be a pro-apoptotic protein is of particular interest given the involvement 
ofElB 55-kDa in cellular transformation. 
16 
Introduction to DAXX 
DAXX contains no homology to other known proteins. Murine DAXX 
(mDAXX) was originally identified as binding to the intracellular domain of Fas (also 
named APO- l and CD95) in a two-hybrid screen by Yang et al. ( 1997). They showed 
that the overexpression of mDAXX and Fas together enhanced Fas-mediated apoptosis 
through the Jun N-terminal kinase (JNK) pathway. Fas is a member of the tumor 
necrosis factor (TNF) receptor superfamily and is activated when immune effector cells 
deliver Fas ligand (FasL) to the receptor. Conflicting stories have emerged regarding the 
role of DA.XX in Fas-induced apoptosis. In 1999, Torii et al. showed that sensitivity to 
apoptosis induced by Fas was enhanced in cells overexpressing the human homologue of 
mDAXX. This cellular response was specific to Fas. Apoptosis induced by other TNF-
family death receptors was not atîected. They reported accelerated activation of caspases 
but no increase in JNK. activity. Surprisingly, DA.XX may play an anti-apoptotic role in 
mouse development (Michaelson et al., 1999). A deficiency in DAXX results in 
extensive apoptosis and embryonic lethality. A recent report claims that Fas-mediated 
cell death does not involve DAXX (Villunger et al., 2000). A dominant-interfering 
mutant of DAXX was used in these experiments although they admitted 1:hat higher 
levels of the mutant might have had an effect on FasL-induced apoptosis. 
Torii et al. (1999) also showed that DAXX is in fact a nuclear protein that 
localizes to structures called PML oncogenic domains (PODs) but does not bind Fas. 
PODs are essentially accumulations of proteins and these multiprotein complexes 
17 
associate with the nuclear matrix (Ascoli and Maul, 1991). There are approximately 10-
30 PODs per cell nucleus. In normal cells, PML is concentrated within these structures 
and is critical to the formation of PODs (lshov et al., 1999). Apart from PML and 
DAXX, other proteins found in PODs include: p53 (Fogal et al., 2000), co-activator and 
histone acetyl transferase, CBP (LaMorte et al., 1998), SplOO recognized by 
autoantibodies from patients with primary biliary cirrhosis (reviewed in Stemsdorf et al., 
1997), BML, the RecQ helicase missing in Bloom's syndrome (Zhong et al., 1999), and 
pRb (Alcalay et al., 1998) (illustrated in figure 4). The localization of ail other proteins 
to PODs is dependent on SUM0-1 modification of PML (Zhong et al., 2000a). The 
fonction of these nuclear bodies in the cell is still not clear but there is evidence for their 
involvement in DNA replication, transcriptional activation and apoptosis (reviewed in 
Hodges et al., 1998). PML is a cell growth and tumor suppressor protein essential for 
multiple apoptotic signais (Wang et al., 1998). These include IFN, TNF, Fas, and 
ceramidc, normally employed to induce apoptosis upon DNA damage or neoplastic 
transformation. PML is found fused to the retinoic acid receptor-alpha (RARa) in acute 
promyelocytic leukemia (APL) due to a distinct chromosomal translocation, t(15; 17) 
(reviewed in Melnick and Licht, 1999). The resulting PMLIRARa fusion protein 
contributes to the pathogenesis of APL. PMLIRARa can heterodimerize witb PML and 
protect cells from apopt_osis, thus acting in a dominant negative manner (Wang et. al. 
1998). Also, due to the presence of the fusion protein, PML can no longer mediate 
assembly of PML nuclear bodies (Dyck et al., 1994; Weis et al., 1994). 
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DAXX interacts physically with PML and localizes to PODs in mitogen-
activated splenocytes (Zhong et al., 2000b ). The sequestering of DA.XX in PODs by 
PML is necessary for its pro-apoptotic function (Torii et al., 1999). A mutant DA.XX that 
could no longer localize to PODs was unable to enhance Fas-induced apoptosis. By 
sequestering DAXX in PODs, the PML protein also inhibits the repressor fonction of 
DAXX (Li et al., 2000a). DAXX possesses strong transcriptional repressor activity 
(Hollenbach et al., 1999; Torri et al., 1999) and so it is possible that DA.XX plays a role 
in programmed cell death by modulating the transcription of certain genes. This 
repressor fonction may result from the recruitment of HDACs by DA.XX (Li et al., 
2000b). HDAC inhibitor, TSA, blocks DAXX repressor activity. DAXX interacts with 
transcription factor ETS 1 and prevents transactivation of at least two genes regulated by 
ETS l: MMP 1, involved in the process of tumor invasion and metastasis, and Bcl2, which 
is anti-apoptotic (Twasaka et al., 1996; Li et al., 2000b). 
PODs increase both in size and number following interferon (IFN) 
treatment of cells and may be sites for antiviral defense mechanisms (Hodges et al., 
1998). IFNs are growth regulatory cytokines with antiviral activity (reviewed in Jokik, 
1991 ). IFN treatment also dissociates DA.XX from centromeres and results in the 
association of DAXX with PODs (Everett et al., 1999). Several viruses express proteins 
that specifically modify PODs, including adenoviruses, herpes simplex virus type 1, 
cytomegalovirus, and hwnan T-cell leukemia virus. ElB 55-kDa itself localizes to PODs 
shortly after adenovirus infection, along with E4orf3 (Doucas et al., 1996). PODs then 
undergo a dramatic morphological change from spherical structures to fibrous-like 
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tracks. Host factors are recruited, along with ElB 55-kDa. from the PODs to viral 
inclusion bodies, which are sites of adenovirus DNA replication and late RNA 
transcription (illustrated in figure 4 }. E4orf3 remains behind in tracks with PML. 
Experiments with adenovirus deletion mutants point to E4orf3 as the viral protein 
responsible for POD reorganization, with E lB 55-kDa contributing to the sequential 
redistribution of POD proteins. However, immunofluorescence co-localization 
experiments perforrned here show that ElB 55-kDa itself is capable of disrupting the 
interaction between DAXX and PML, as well as the formation of PODs. These results 
suggest that another mechanism by which ElB contributes to cellular transformation may 





NDP55 HP l/SplOO-SUM0-1 
DAXXI RML-SUM0-1 
Figure 4: Adenovirus infection leads to disruption of PODs. 
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Shortly a:fter adenovirus infection ElB 55-kDa and E4orf3 associate with PODs, which undergo a 
dramatic morphological change into fibrous-like tracks, illustrated here. Host factors are recruited 






Materials and Methods 
Y east Two-Hybrid Assays 
Yeast two-hybrid assays were performed with Ad2 ElB 55-k.Da (aa 155-495) 
fused to the Gal4 BD in plasmid pGBDU-Cl along with either Saccharomyces cerevisiae 
genomic library fragments in plasmid pGAD-C 1, or human Hela cDNA library fragments 
in plasmid pGAD GH, fused to the Gal4 AD (pre-made MA TCHMAKER plasmid 
libraries, CLONTECH Laboratories, Inc. ). Two-hybrid assays were also performed with 
the carboxyl-terminal of DAXX (aa 621-740) fused to the Gal4 AD, isolated from library 
screening (described below) and several Ad ElB 55-kDa fragments (Ad2 ElB aa l-437, 
155-495, and 437-495; Ad12 ElB full length, aa 1-408, and 1-204) fused to the Gal4 BD, 
cloned into pGBDU-C(X) plasmids. Adenovirus E 1 B constructs were cloned into 
plasmids by restriction endonuclease digestion and ligation. The yeast strain used for all 
two-hybrid assays was PJ69-4A (MATa trpl-190 leu2-3,112 ura3-52 his3-200 gal4LJ 
ga/80LJ LYS2::GALJ-HIS3 GAL2-ADE2 met2::GAL7-lacZ) outlined in James et al. 
(1996). 
Co-transformation of plasmids in yeast was done by the basic lithium acetate 
(LiOAc) method. Several host yeast colonies were used to inoculate synthetic dropout 
(SD) liquid medium lacking lysine (lys). Cultures were grown overnight at 30°C to an 
OD6oo between 0.8 and 1.0, centrifuged at 2,600 rpm for 5 min at RT then washed 2x 
with sterile H20 and lx with filtered LiOAc solution. Pellets were resuspended in 0.5 ml 
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LiOAc solution for each 50 ml of culture. Next, 0.1 ml of the suspension was added to a 
1.5 ml eppendorf containing 10 µg of each plasmid DNA. To test for the presence of 
contaminants, a control without DNA (H20) was perfonned for each round of 
transformation. The mixture was left at RT for 10 min, then 0.28 ml of 50% filtered 
PEG/LiAc solution was added. The tubes were placed at 30°C for 1 hr. 43 µI DMSO was 
added and the samples were heat shocked at 42°C for 5 min. After washing 3x with 
sterile H20, the pellet was resuspended in 1 ml sterile H20. 2 volumes of the suspension 
(0.15 ml and 0.3 ml) were plated onto SD lysleu-ura- to select for both the pGAD 
plasmid which contains the gene for leucine (leu2) and the pGBDU plasmid which 
contains the gene for uracil (ura3) and incubated 72 hr at 30°C. Where water was used in 
place of plasmid DNA, no colonies should appear after three days incubation. A single 
yeast colony was picked from each plate and streaked again onto SD lys-leu-ura-. Plates 
were incubated at 30°C for 48 hrs after which single colonies could be picked and 
streaked on different SD plates. Protein-protein interactions were recognized by: /. 
growth on SD his- + agar in the presence of 5 mM 3-amino-1,2,4-triazole (3-AT) to 
inhibit hi:d reporter gene auto-activation, 2. growth on SD ade-, and 3. detection of P-
galactosidase activity in the presence of X-Gal (5-bromo-4-chloro-3-indolyl-P-D-
galactopyranoside ). 
To perform the J3-galactosidase assays, single colonies (triplicate for each co-
transfonnation) were spread in a straight line on SD lysleu-ura-+ agar and placed at 30°C 
ovemight. A mixture of 5 ml 1 % agarose in H20, 5 ml heated sodium phosphate buffer, 
0.1 ml 10% SOS and 0.2 ml X-Gal was poured over each plate. Following agarose 
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solidification plates were incubated at 37°C for l hr. By this time, enzyme-producing 
yeast colonies appear blue. The interaction between Ad2 ElB 55-kDa (aa 155-495) in 
pGBDU and full length p53 in pGAD was used as a positive control in f3-galactosidase 
assays as well as growth on selective media. Negative controls consisted of replacing 
one of the co-transformants with empty pGAD or with empty pGBDU. 
Library Screening 
Figure 5 outlines the steps involved in the identification of Ad2 ElB 55-kDa-
interacting proteins. Ad2 ElB 55-kDa (aa 155-495) in pGBDU-Cl (hait) and expression 
library fragments in pGAD-Cl or pGAD GH (prey) were co-transformed into yeast as 
described above. Between 5,000 and 8,000 colonies were obtained for each plate. Yeast 
colonies possessing both plasmids of interest were replica plated onto SD bis- + 5 mM 3-
AT and SD ade-. Those colonies that grew on both plates were picked and grown on SD 
lysleu-ura-ade· to select for protein-protein interaction and ensure plasmid co-
segregation. Colonies were then grown on SD leu- + agar with the addition of 5-
fluoroorotic acid (5-FOA) (selects for the loss of the pGBDU/Ad2 ElB plasmid). These 
colonies were replica plated onto SD ade- plates. Colonies that grew on SD ade- + agar 
in the absence of Ad2 ElB 55-kDa were considered false positives and discarded. The 
majority of colonies were lost at this step. Recovery of potential positives consisted of 
isolation of plasmid DNA from yeast and amplification in E. co/i. 
GAIA BD-Ad2 ElB 55-kDa / Gal4 AD-library protein 
co-transformation in PJ69-4A 
Selection for reporter gene activation 
(SD Ade· and His-+ 5mM 3-AT) 
Test for plasmid co-segregation on SD lys"leu·ura· 
Removal of the Ad2 ElB hait on 5-FOA leu· 
l 
Colonies that do not 
grow on SD Ade· 
Colonies that 
grow on SD Ade· 
are false positives 
Retrieval of AD plasmid DNA from yeast 
and amplification in bacteria .. 
Co-transformation in PJ69-4A ofpotential positives along 
with Ga14 BD-Ad2 ElB 55-kDa or the Ga14 BD alone 
1 
Sequencing and identification 
oftrue positives 
False positives can activate 
transcription of reporter genes 
with the Gal4 BD alone 
Figure 5: Method used to screen for Ad2 ElB 55-kDa-interacting proteins. 
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The S. cerevisiae genomic library and the Hela cDNA library were screened with Ad2 EIB 
55-kDa as bait. Several steps are involved in the elimination of false positives. True 
positives are proteins, encoded by expression library DNA fragments, which can activate 





In order to extract plasmid DNA from yeast, 0.1 ml of liquid SD lys-leu- was 
inoculated with one positive yeast colony. The culture was grown at 30°C to an 00600 
between 0.8 and 1.0 and centrifuged for 5 min at 2,600 rpm (here the pellet could be 
frozen for later use). Cells were washed 2x with sterile H20 and 1 x with LETS buffer. 
The pellet was resuspended in 0.3 ml LETS and transferred to a 15 ml tube. 0.3 ml of 
phenol was added followed by glass beads to the surface of the liquid ( 1 eppendorf of 
beads). Next, the tube was vortexed 6x 30 sec at maximum speed alternating with 30 sec 
on ice. The supernatant was transferred to an eppendorf and the glass beads were washed 
lx with 0.15 ml LETS and lx with 0.15 ml chloroform, collecting the liquid each time in 
the eppendorf. One volume of phenol/chloroform was added to the eppendorf which was 
then vortexed for several seconds and centrifuged at 12,000 rpm for 5 min at RT. The 
DNA in the upper phase was removed and precipitated with 95% ethanol and salt for l 0 
min at -20°C. The pellet was washed with 95% ethanol and resuspended in 0.3 ml H20. 
5 µl RNase A (10 mg/ml) was added and the sample was incubated at 37°C for 10 min. 
A second phenol/chloroform extraction and ethanol precipitation was performed at this 
step and the pellet was resuspended in 20 µl sterile H20. 
Y east DNA (3 µl) was analyzed on a 0.8% agarose gel and later amplified in E. 
coti (XL 1 Blue) by electroporation. 1-5 µl of DNA was mixed with 40 µl of competent 
cells and electroporated at 1.8 kV (Bio-Rad Gene Pulser, 25 µF with the pulse controller 
set to 200 ohms). Following electroporation, 0.2 ml of YT was added to the cuvette and 





incubated at 3 7°C overnight. A single colony was used to inoculate 2 ml YT + Amp . 
After shaking overnight at 3 7°C, 0.1 ml of this culture was used to inoculate 250 ml YT + 
Amp and again grown overnight at 3 7°C. Bacterial cells were harvested by centrifugation 
at 6,000 rpm for 15 min at 4°C and resuspended completely in 10 ml solution I. The cell 
suspension was transferred to a 50 ml centrifuge tube. 10 ml solution II was added and 
the tube was inverted 4-6 times to mix and incubated at RT for 5 min. 10 ml cold 
solution III was added to the lysate and mixed by inversion followed by 30 min 
incubation on ice. After 30 min centrifugation at 15,000 rpm at 4°C, the supernatant was 
divided into two clean 50 ml centrifuge tubes and each was mixed with 11 ml 
isopropanol. Tubes were centrifuged immediately at 11,000 rpm at 4°C for 30 min. The 
DNA pellet was washed with 5 ml 70% ethanol, air-dried and resuspended in 0.5 ml 
distilled HiO by vortexing. The DNA solution was transferred to an eppendorf. 5 µl 
RNase A (10 mg/ml) was added and the sample was incubated at 37°C for l hr. 
Extraction with 0.5 ml phenol consisted of vortexing for several seconds, centrifugation 
at full speed for 5 min and transferring the upper phase to a clean eppendorf. The 
extraction was repeated with 0.5 ml phenol/chloroform. 50 µl 3 M NaOAc (pH 5.3) and 
0.42 ml isopropanol were added to precipitate the DNA followed by centrifugation at full 
speed for 10 min. The pellet was washed lx with 0.25 ml 70% ethanol and lx with 0.25 
ml 95% ethanol, dried and resuspended in 0.2 ml TE. The DNA concentration was 
determined by measuring the OD 260 (1 OD26o = 50 µg DNA/ml). 
pGAD vectors containing the fragments of interest were then co-transformed back 
into yeast along with either Ad2 ElB 55-kDa in pGBDU-Cl or the pGBDU-Cl plasmid 
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alone. Those library proteins possessing intrinsic DNA-binding ability or those that 
could activate transcription of reporter genes, ade2, his3, and !acZ, through association 
with the Gal4 BD alone were eliminated at this step. Only those positive interactions 
dependent on the presence of Ad2 ElB 55-k.Da were considered true. True pos!tives 
were sequenced using the DNA sequencing procedure originally described by Sanger and 
Coulson (1975). The primer used for sequencing was 5'-gatgatgaagatacccc-3', present in 
the Gal4 AD. The proteins were identified via an on-line BLAST search at the National 
Center for Biotechnology Infonnation web site. 
Protein Expression and Purification 
The coding regions of UbcH7wt and UbcH7 âE2 were generated by PCR, tagged 
with FLAG at the 5' end and 6X His at the 3' end, and cloned into pET22b( + ). The 
proteins were expressed in E. coli BL2l(DE3) upon IPTG induction. To do this, a single 
colony containing the plasmid of interest was picked to inoculate 1 OO ml YT + Amp and 
grown ovemight in a 37°C shaker. This culture was diluted 1:10 (25 ml in 250 ml YT + 
Amp) and incubated at 30°C until the 00600 was 0.6. IPTG was added .to a final 
concentration of 0.4 mM and flasks were placed at 30°C for 4 hrs. The proteins were 
then purified using nickel-nitrilotriacetic acid (Ni-NT A) agarose. Cells were harvested 
by centrifugation at 8,000 rpm at 4°C for 10 min. The pellet was resuspended in 12 ml 
ice-cold His binding buffer and transferred to two 50 ml tubes. Each was sonicated (at 
power setting 10 on the sonicator) lOx 20 seconds, centrifüged at 16,000 rpm for 10 min 
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at 4°C, and filtered. Resin was prepared by adding 10 ml His binding buffer to 2 ml Ni-
NTA agarose. After 3 min centrifugation at 1,200 rpm, 1 ml of resin remained. 10 ml 
His binding buffer was added and this was placed at 4°C for 2 hrs, rotating. The resin 
was spun down and washed 4x with lO ml His washing buffer before eluting with 5x 1 
ml His elution buffer. lO µI of each elution was examined on a 12% SOS PAGE gel run 
at 150 volts in electrophoresis buffer. The gel was stained with Coomassie Brilliant blue 
for l 0 min at RT and incubated ovemight in de-stain solution. Eluted proteins were 
dialyzed by transferring the liquid into dialysis tubing secured with clamps. These were 
placed in dialysis buffer, stirring, ovemight at 4°C. The protein concentrations were 
determined by preparing three dilutions of bovine serum abumin (BSA) as a protein 
standard. Standard and sample solutions in 0.8 ml H20 were added to 0.2 ml of Bio-Rad 
dye reagent, vortexed, and the absorbance measured at 595 nm. A standard curve was 
plotted for BSA and used to determine sample concentrations. Ad2 E 1 B 55-kDa was 
expressed in insect cells and affinity purified with Ni-NT A agarose. 
Immunoprecipitation 
UbcH7 L\E2 (200 ng) purified from E. co/i was incubated with monoclonal 
antibody, 2A6, against À.d2 ElB 55-kDa (0.15 ml of hybridoma supematant), or with 
both 2A6 and Ad2 EIB 55-kDa (100 ng) for l hr at 4°C, rotating. 15 µlof protein G-
agarose beads was added and incubated for l hr at 4°C, rotating. Following 





buffer 1. This step was repeated with wash buffer 2 and wash buffer 3. Beads were then 
resuspended in 20 µl SOS loading buffer and placed at 1 oo0c for three min. The 
precipitates were separated on a 12% gel by SOS-PAGE and the proteins were transfcrred 
to a nitrocellulose membrane (Ply Screen PVDF transfer membrane) for 2 hrs at 150 volts 
at 4°C in transfer buffer to be analyzed by Western blot. The membrane was blocked for 
lhr at RT with 5% milk in Tris-buffered saline (TBS) and 0.1% Tween 20 and probed 
with monoclonal antibody against the FLAG epitope ( 1: 1000 dilution in blocking buffer) 
for 1 hr at RT. Following washes with TBS-Tween 20 (3x 10 min at RT), the membrane 
was incubated with secondary antibody, goat anti-mouse for 1 hr (1: 1000 dilution in 
blocking buffer). The membrane was treated with enhanced luminol reagent (NEN Life 
Science Technologies) for 60 sec and exposed to film . 
Cell Culture 
Three different cell lines were cultured: G401, a rhabdoid kidney tumor cell line, 
0401 CC3, a derivative of G401 expressing Adl2 ElB 55-kDa protein and 293, human 
embryonic kidney cells expressing AdS ElA and ElB proteins. 293, G401, G401 CC3, 
cells were grown in DMEM medium supplemented with 10% fetal bovine serum. Added 
to the 0401 and 0401 CC3 media were 15 µg/ml hypoxanthine, and 10 µg/ml thymidine. 
G401 CC3 medium also contained 250 µg/ml G418. Cells were incubated in a 






The localization patterns of PML and DAXX were examined in three different 
cell lines: G40l, 0401 CC3, and 293. Cells were grown ovemight on a glass coverslip to 
approximately 70% confluence, fixed with 4% paraformaldehyde for 20 min at room 
temperature (Rn and permeabilized with 0.2% Triton X in PBS for 15 min at RT. After 
blocking for one hour in blocking buffer (2% fetal bovine serum, 0.1 % sodium azide, 
0.1 % Tween 20 in PBS) the cells were incubated with both a rabbit anti-DAXX antibody 
(1 :500 dilution in blocking buffer) and a mouse anti-PML antibody (l :250 dilution in 
blocking buffer) for 2 hrs. The cells were washed 3x with TBS and then incubated for 
l hr with a mixture of fluorochrome-labeled secondary antibodies: goat anti-rabbit 
conjugated to Texas red and FITC-conjugated goat anti-mouse (each diluted 1:100 in 
blocking buffer). The cells were washed again 3x with TBS followed by staining for l 0 
min with 4',6'-diamidino-2-phenylindole (DAPI) (0.2 µg/ml in PBS) at RT. Localization 
of both DAXX and Ad12 EIB 55-kDa was examined in the 0401 CC3 cell line. Cells 
were prepared as above with primary antibodies consisting of mouse anti-DAXX 
antibody (1:500 dilution in blocking buffer), and rabbit alpha-ElB (1:1000 dilution in 
blocking buffer). Fluorochrome-labeled secondary antibodies used were Texas red-
conjugated goat anti-mouse, and FITC-conjugated goat anti-rabbit ( each diluted 1: 1 OO in 
blocking buffer). 
PML cellular localization was also examined in 0401, G401 CC3 and 293 cell 
lines. In place of DAPI, cells were stained with propidium iodide (Pl). Cells were 
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incubated with a mixture of primary antibody, mouse alpha-PMI., and RNase A (0.3 
mg/ml in PBS) for 2hrs at 37°C. The secondary antibody used was FITC-conjugated goat 
anti-mouse. After washing 3x with TBS-Tween 20 the cells were stained for 10 min with 
PI (1.0 µg/ml in PBS) at RT. 
ln ail cases coverslips were mounted and viewed using an Olympus IX-70 
scanning laser biological microscope. An Omnichrome ion laser power supply and NEC 
gas laser power supply were connected to the Olympus Fluoview system. The laser line 
tilter turret was set at 568 and 488 to allow argon and krypton laser combination. The 
laser intensity was set at 0.6 and the confocal aperture at 0.2. Cells were examined with 
the 40X objective (LCPlanFI) with oil. A Lambda l 0-C optical filter changer was used to 
choose the appropriate filters. Images were captured using Fluoview software (version 





Potential Ad2 ElB SS-kDa Cellular Targets 
.. ., _,_ 
The yeast two-hybrid method was employed for screening the Saccharomyces 
cerevisiae genornic library and the Hela cDNA library to identify proteins that associate 
with Ad E 1 B 55-kDa. The first step concemed choosing an E 1 B construct that was not 
toxic to cells, did not activate transcription alone, and tested positive in yeast two-hybrid 
assays against a protein that it was known to interact with. This last step would help to 
assure that the EIB/Gal4 DNA-binding domain (BD) fusion protein was properly folded. 
Ad2 ElB 55-kDa (aa 155-495) fused to the Gal4 BD was the hait hybrid used for library 
screening. lt associates with itself and with p53 fused to the Gal4 transcription activation 
domain (AD) in two-hybrid assays (data not shown). Proteins encoded by pre-made 
MATCHMAKER plasmid libraries were fused to the Gal4 AD. The insert size range was 
0.4 - 2.0 kb with an average insert size of 1.5 kb. 
The rationale behind screening a yeast library with the large human adenovirus 
E 1 B protein was that hurnan homologues of yeast proteins positive for E 1 B-binding, or 
evolutionarily conserved functional domains, could be identified. The complete DNA 
sequence of the S. cerevisiae genorne has been determined and made available on the 
web. Altematively, the biological effects of interactions could be studied in yeast where 
many cellular processes are less complex. Partial screening of the S. cerevisiae genomic 





55-k.Da binding. These proteins are listed in table 3 along with their functions in yeast 
and comparison to human sequences. 
Potential S. cerevisiae Ad2 ElB 55-k.Da-interacting proteins include UFDl, for 
ybiquitin (Ub) fusion Q.egradation, a 40-k.Da protein essential for cell survival in yeast 
(Johnson et al., 1995). UFD 1 bas not been fully characterized but it is implicated at a 
post-ubiquitination step of the Ub-fusion degradation pathway. UFD 1 is also found 
complexed to Np 14, implicated in nuclear transport (Meyer et al., 2000). A human 
homologue ofUFDl, called UFDlL, has been described as a potential housekeeping gene 
(Novelli et al., 1998). UFD 1 L haploinsufficiency contributes to the phenotype seen in 
22q 11 deletion syndrome (Y amagishi et al., 1999). Next is RIS l (also known as DIS 1 ) . 
RIS 1 interferes with silencing and may act by increasing accessibility of silenced DNA. 
It is a member of the SWl/SNF2 family of DNA-dependent ATPases (Zhang and 
Buchman, 1997) and shares sequence homology with a number of human proteins 
including DNA-dependent A TPases, helicases, repair protein ERCC6, and centromere 
protein, CENP-F. The region covered by both RIS 1 cDNA fragments identified by 
library screening shows CENP-F homology. CENP-F is a cell cycle specific nuclear 
autoantigen that associates with both the nuclear matrix and centromeres (Liao et al., 
1995). To determine whether it binds to Ad2 ElB 55-k.Da, CENP-F was cloned into the 
pGAD plasmid. Gal4 AD/CENP-F interacted with the Gal4 BD/Ad2 ElB 55-k.Da in 
yeast two-hybrid assays but not with Gal4 BD alone (data not shown). Next is Bdf2, 
functionally redundant with Bdfl and homologous to the carboxyl-terminal half of 





Bdfl, Bdf2, and TAFu250 each contain two copies of the bromodomain, a 110 amino 
acid module conserved from yeast to human (Jeanmougin et al., 1997). T Af 11250 may 
consist of two separate proteins in yeast, Bdfl/Bdf2 and Tafl45 which possesses 
acetyltransferase activity. The bromodomain is found in other histone acetyltransferases 
(HATs) including P/CAF, p300/CBP and in the ATPase subunit of SWI/SNF and their 
homologues. Despite widespread conservation the functional significance of the 
bromodomain remains unknown although evidence suggests that it may play a role in 
chromatin remodeling. lt was demonstrated that the bromodomain has specificity for 
acetyl-lysine (Dhalluin et al., 1999) and interacts with histones H3 and H4 (Owen et al., 
2000 and references therein). A fragment of Bdfl that includes one of the two 
bromodomains has binding affinity for H3 and H4 (Pamblanco et al., 200 l ). Also, a 
recent study indicates that the bromodomain of p300 mediates stable association with 
chromatin (Manning et al., 2001). Next is Fobl, shown to be required for recombination 
hot spot activity and replication fork blocking within ribosomal RNA genes (rDNA) 
(Kobayashi and Horiuchi, 1996; Kobayashi et al., 1998). This block has been linked to 
the generation of circular species of rDNA and aging in yeast (Defossez et al., 1999). 
Next is FlRl. Relatively little is known about FIRl except that it interacts with REF2 in 
yeast two-hybrid assays (Russnak et al., 1996). REF2 is responsible for the 3' end 
cleavage of yeast mRNA prior to the addition of a poly-A tail. Another hit resulting from 
screening the yeast library was KRll. KRll interacts with KRRl ( containing a KRR 
motif) to fonn a complex that is required for formation of 40S ribosome subunits in the 
nucleolus (Sasaki et al., 2000). Both proteins are conserved among eukaryotes. Two Yap 





found to bind Ad2 ElB 55-kDa in yeast two-hybrid assays. Yap proteins are AP-l 
factors with distinct DNA-binding specificity (Fernandes et al., 1997). There are a total 
of eight Yap family members defined by particular residues within the basic region of the 
bZIP domain. Y ap4 differs from all other Y ap pro teins in that Y ap4 mutations increase 
chromosome instability. Unknown open reading frames not listed in table 3 are: 
YHR134w, YHR073w, YPL138C, and YPL277C . 
• • • 
Table 3: S. cerevisiae proteins positive for interaction with Ad2 E1B 55-kDa 
ldentity Size and Span Chromosome Protein Protein Comments Compared with Human Protein Sequences ofFraament Location SizelkDa Location 
Ufd1 700 bp begins 438 bp 3' of the 7 40 cytoplasm Acis at a post-ubiquitination step of the Human Ufd1 L is missing in 22q11 deletion ORF start lORF=1086 bDl ubiouitin-fusion degradation oathwav svndrome 
4 kb and 900 bp both begin 
Previously DIS1 - involved in silencing Homology to human ERCC6, CENP-F, DNA-RIS1 1005 bp 3' of the ORF start 15 184 nucleus dependent ATPases, helicases and hsnf2h lORF=4860 bp) 
2. 7 kb beglns 576 bp 3' of the Unknown function - contains 2 copies of Homologous to the carboxyl-terminal half of Bdf2 ORF, 3 kb beglns 162 bp 3' of 4 72 nucleus the bromodomain mammalian TAFll250 the ORF start lORF=1917 bol 
Replication fork blocking sites have been Fob1 2.2 kb begins 24 bp 3' of the 4 65 nucleolus Replication fork blocking protein ORF start lORF=1701 bD) identified in humans 
FIR1 1 kb begins 2346 bp 3' of the 5 105 ? Also known as PIP1 - unknown function REF2 is involved in 3' end polyadenylation ORF start lORF= 2778 bp) lnteracts with REF2 
2.5 kb and 5 kb both begin 
Unknown function- interacts with KRR1 KRR1 is homologous to human EST of unknown KRl1 555 bp 3' of the ORF start 14 69 nucleolus function IORF= 1777 bol 
YaP4 1.3kb begins 109 bp 3' of the 15 33 nucleus Also known as cin5 - leucine zipper Yaps were first named as yeast AP-1 factors ORF start lORF=888 bD) transcription factor 






Human proteins positive for Ad2 ElB 55-kDa binding were detennined through 
partial screening of the Hela cDNA library (700 000 transformants). A total of 11 
different proteins have been identified. These are listed, along with their functions and 
other features, in table 4. Excluded from tables 3 and 4 are "nonsense' peptides, cloned 
out of frame or in the reverse orientation. As a result of Hela cDNA library screening Ub 
was found to bind Ad2 E 1 B 55-kDa. Ub is a highly conserved protein consisting of 76 
amino acid residues. Covalent ligation to Ub targets abnormal or short-lived proteins for 
degradation by the 26S proteasome. The minimum signal for efficient proteasomal 
targeting is a tetra-Ub chain (Thrower et al., 2000). There are three classes of enzymes 
involved in ubiquitination: the E 1, or Ub-activating enzyme, leads to activated Ub which 
is covalently linked to E 1 via a thioester bond. Activated Ub is transferred to the E2, or 
Ub-conjugating enzyme, which may donate Ub directly to proteins or may require an E3, 
or Ub-protein ligase, thought to play a role in substrate recognition. The human Ub-
conjugating enzyme, UbcH7 (also called E2Fl) was picked up from library screening. 
UbcH7 is a 17-kDa protein responsible for Ub-mediated degradation of the tumor 
suppressor protein, p53 (Ciechanover, et al., 1994) and oncoprotein c-fos (Stancovski et 
al., 1995). Proteolysis of p53 and c-fos by this degradation pathway allows for rapid 
changes in protein level. UbcH7 is also responsible for processing of the NfKB precursor 
p 105 (Orian et al., 1995). p 105 is degraded to the p50 subunit of the transcription factor 
NfKB which targets genes involved in cell growth and differentiation, inflammation, 
lymphocyte activation, and the acute-phase response. SUM0-1, an acronym for §.mail 
Ub-like modifier, was also found to bind to Ad2 ElB 55-kDa as a result of library 





similar to ubiquitination, referred to as sumolation (Kamitani et al., 1997). It consists of 
101 amino acid residues, 18% identical and 48% similar to Ub. Unlike Ub, however, the 
post-translational conjugation of SUM0-1 to various proteins does not target them for 
degradation. A growing list of cellular proteins known to be modified by SUM0-1 
includes p53 (Gostissa et al., 1999), RanGAPl (Matunis et al., 1996), and PML (Boddy et 
al., 1996). The conjugation of SUM0-1 to p53 has been reported to result in an increase 
in p53 transactivation activity by some (Gostissa et al., 1999; Rodriguez et al., 1999) but 
contradicted recently by Kwek et al. (2001). Sumolation localizes RanGAPl to the 
nuclear pore complex (NPC) (Matunis et al., 1996). RanGAPl is a regulator of the Ran 
GTP/GDP cycle and therefore the bi-directional transport of proteins and 
ribonucleoproteins across the NPC (Melchior et al., 1993; Moore and Bio bel. 1993 ) . 
Three molecules of SUM0-1 are conjugated to PML at three separate sites (Kamitani et 
al.. 1998) whereas only one molecule is conjugated to other SUM0-1 protein targets. 
Sumolation of PML is a prerequisite for POD (PML oncogenic domain) formation. 
affecting the localization of PML and thus ail other POD components to the nuclear 
structures (Zhong et al., 2000a). Adenoviruses specifically modify PODs, with El B 55-
kDa itself localizing to PODs shortly after infection (Doucas et al., 1996). During the 
preparation of this manuscript it was reported by Endter et al. (2001) that Ad5 ElB 55-
kDa could be modified by SUM0-1 in vivo at a single lysine residue (Kl04). Sumolation 
affects El B subcellular localization and is required for inhibition of p53 transactivation 
function and transformation by Ad5 ElB 55-kDa. Next in the list of potential ElB 55-





apoptosis (Torii et al., 1999; Yang et al., 1997). DAXX interacts with SUM0-1-modificd 
PML and localizes to PODs (Torii et al., 1999). 
Aside from Ub, UbcH7, SUM0-1, and DAXX, other potential human Ad2 El B 
55-k.Da-interacting proteins include CLK l, which phosphorylates serine/arginine-rich 
(SR) proteins. SR proteins are essential splicing factors (Caceres et al., 1994; Fu, 1993) 
thought to be regulated by phosphorylation (Xu and Manley, 1997). CLKl may play a 
role in the alternative splicing patterns during the switch from early to late phase of 
adenovirus replication. Overexpression of CLKl kinase shifted the splicing of El Apre-
mRNA from multiple mRNA products, 9S, l2S and l3S, to the 9S RNA isoform 
characteristic of the late phase of infection by adenovirus (Duncan et al.. 1997). Next is 
MCM2, required for initiation of DNA replication (Todorov et al., 1994) and implicated 
in transcription by RNA polymerase II (Yankulov et al., 1999). MCM2 is a mini-
chromosome maintenance protein, of which there are at least six (MCM2-7). ln ail 
eukaryotes MCM2-7 ensure that DNA replicates only once in each cell cycle (for a 
review on MCM2-7 see Tye, 1999). During the transition from G 1-phase to S-phase 
MCM2-7 are loaded onto replication origins as part of the pre-replication complex. 
Phosphorylation of MCM2 alters the conformation of the MCM complex and leads to 
melting of origin DNA. Next is GG2-l, induced by TNF but of unknown function 
(Horrevoets et al., 1999). GG2-l shows no homology at the nucleotide, amino acid, or 
structural level with any protein or gene present in the combined NCBI and EMBL 
databases. Another potential ElB partner is NTHl, a functional human homologue of E . 





in pyrimidine base excision repair. Next is y-Glutamyl hydrolase (GGH). GGH is a 
ubiquitous enzyme highly sequestered in the lysosome (Waltham et al., 1997). It has both 
exo- and endopeptidase activity and is implicated in antifolate resistance. Next is 
PMSCLl, a component of the PM-SCL particle, a multi subunit complex recognized by 
autoimmune sera of patients suffering from polymyositis/scleroderma overlap syndrome. 
PM-SCL proteins are thought to function in RNA processing and degradation pathways 
(Allmang et al., 1999; Briggs et al., 1998). Lastly is metastasis-associated protein. 
MTAl. MTAl overexpression correlates with tumor invasiveness and the presence of 
metastases (Toh et al., 1997). MTAl may interact with HDACl (Toh et al., 2000) 
although a role for MT A 1 in the alteration of chromatin structure has not been uncovered . 
• • • 
Table 4: Human proteins positive for interaction with Ad2 E1B 55-kDa 
ldentity Size and Span Chromosome Prote in Protein Functions of Fraament location Size lkDal location 
2 x 600 bp, both begin 70 bp 3' of the pseudogenes/ Can be conjugated to other proteins marking them for Ublquitin ORF start and 450 bp beglns 59 bp 3' of 12q24.3/ 8.6 cytoplasm degradation by the proteasome the ORF start CORF=487 bol 17P11.2-12 
UbcH7 850 bp covers entire ORF (465bp), 22q11.2 17 cytoplasm Ubiquitin-conjugating enzyme specific for c-fos, NFkB, p53 missim:1 exon 2 of 4 and c-mvc 
SUM0-1 1.1 kb covers entire ORF (305 bp) 2q33 22 cytoplasm Can be conjugated to other proteins in a manner similar to ubiauitination 
DAXX 2 x 600 bp, both begin 1860 bp 3' of the 6p21.3 120 nucleus/ Stimulates Fas-induced apoptosis ORF start CORF=2220 bp) cvtoolasm 
CLK-1 1.1 kb begins 83 bp 5' of the ORF start 2q33 57 nucleus/ Protein kinase which plays a role in alternative splicing 'alternativelv soliced: 5.6. 3.2, 1.8, 1.7 kbl cvtoolasm 
MCM2 300 bp begins 1584 bp 3' of the ORF start 3q21 125 nucleus Minichromosome maintanance protein involved in the lORF=1631 bol initiation of DNA svnthesis 
GG2-1 1.6 and 1.5 kb cover entire ORF 5 ? ? Unknown function, TNF-induced tORF=567 bol 
NTH1 900 bp begins 42 bp 3' of the ORF start 16p13 36 nucleus Functional homologue of E. coti endonuclease Ill lORF=1028 bPl 
GGH 1.3 kb covers entire ORF (704 bp) 8 36 lysosome Gamma-glutamyl hydrolase, lysosomal peptidase involved in production of folie acid 
PMSCL1 1.2 kb begins 233 bp 3' of the ORF start 4q27 75 nucleolus Polyomyositis/scleroderrna autoantigen 10RF=1119 bol lORF=1119 bol 






Ad2 ElB 55-k.Da lnteracts With a Form of UbcH7 Missing Exon 2 
cDNA sequencing revealed that the Ub-conjugating enzyme, UbcH7, identified by 
He la cDNA library screening with Ad2 E 1 B 55-kDa as hait, is missing exon 2. UbcH7 is 
normally spliced to a 462 bp product consisting of 4 exons (Moynihan et al., 1998). The 
UbcH7 found (àE2) is 348 bp consisting of exons 1, 3, and 4. This altematively spliced 
variant has not been described in the literature. Figure 6 shows an alignment between 
wild type (wt) UbcH7 and UbcH7 ~E2 picked up from screening. The cDNA obtained in 
the yeast two-hybrid screen represented the entire open reading frame, with the exception 
of exon 2, beginning 11 bp N-terminal of the start methionine and including untranslated 
sequence 3' of the stop codon. The coding regions of UbcH7wt and UbcH7 ~E2 were 
generated by PCR and tagged with FLAG at the 5' end and 6X His at the 3' end. 
Recombinant fusion proteins were expressed in E. coli and purified with Ni-NT A 
agarose. Proteins were resolved on a 12% polyacrylamide gel by SDS PAGE and stained 
with Coomassie Brilliant blue. The apparent molecular mass of tagged UbcH7 ~E2 is 
approximately 15-kDa (figure 7B), compared to UbcH7wt at approximately 17-kDa 
(figure 7 A). To verify yeast two-hybrid results, the interaction between Ad2 El B 55-kDa 
and UbcH7 àE2 was assayed by immunoprecipitation (figure 7C). FLAG/His tagged 
UbcH7àE2 was incubated overnight with monoclonal antibody 2A6 against Ad2 ElB 55-
kDa or with both 2A6 and Ad2 EIB 55-kDa purified from insect cells. In both cases 
protein sepharose beads were present in the mixture. The Western blot antibody against 





the presence of the ElB protein (figure 7C, lane 2), indicating that the two proteins 
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ATGGCGGCCÀGCAGGAGGCTGATGAAG--------------------------------- 27 
M A A S R R L M K E L E E l R K C n M K 
UBCH7 wt AACTTCCGT AA CA TCCA GGTTCit\ T GAA GCTAA TTTA TTGA CTT GGCAA GGGCTTA TTGTT 120 
UBCH7 AE2 --- --- ------ --- -- -- ----- --- --- --- ----- ---- ----- -- - --- ---.----
NI .. RN I Q VD E AN LI.TWQ G LI V 
u 
UBCH7 wt CCTGA CAACCCTCCAT ATGA TAA GGGA GCCTTCA GA.A TCGAAA TCAACTTTCCA GCA GAG 180 
UBCH7 Af:2 -- -GACAACCCTCCATATGATAAGGGAGCCTTCAGAATCGAAATCAACTTTCCAGCAGAG 84 
P ON P PYDKG AFR I E IN F PAE 
UBCH7wt TACCCATTCAAACCACCGAAGATCACATTTAAAACAAAGATCTATCACCCAAACATCGAC 240 
UBCH7 Af:2 TACCCATTCAAACCACCGAAGATCACATTTAAAACAAAGATCTATCACCCAAACATCGAC 144 
YP F K PP K 1 T FK T K 1YHPN1 D 
UBCH7 wt GAAAA GGGGCAGGTCTGfCTGCCA Gr AATTA GfGCCGAAAACTGGAAGCCAGCAACCAAA 300 
UBCH7 Af:2 GAAAAGGGGCAGGTCTGfCTGCCAGfAATTAGfGCCGAAAACTGGAAGCCAGCAACCAAA 204 
E KG Q V CL P V 1 SA E NW K PAT K 
.o. 
UBCH7 wt A CC GA CCAA GT AATCCA GTCCCT CA TA GCA CTGGTGAATGA CCCCCA GCCTGA GCA CCCG 360 
UBCH7 Af:2 A CC GA CCAA GTAA TCCA GTCCCTCAT A GCA CTGGTGAATGA CCCCCA GCCTGA GCA CCCG 264 
T D Q V 1QSL1 A LVN D P Q P E HP 
UBCH7wt CTTCGGGCTGACCTAGCTGAAGAATACTCTAAGGACCGTAAAAAATTCTGTAAGAATGCT 420 
UBCH7 Af:2 CTTCGGGCTGACCTAGCTGAAGAATACTCTAAGGACCGTAAAAAATTCTGTAAGAATGCT 324 
LRADL AE E YS K DRKK FCKNA 
UBCH7 wt GAAGAGTTTACAAAGAAATATGGGGAAAAGCGACCTGTGGACTAA 
UBCH7 Af:2 GAAGAGTTTACAAAGAAATATGGGGAAAAGCGACCTGTGGACTAA 
E E F T K KY GE KR P VD * 
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384 
Figure 6: Sequence alignment between wild type UbcH7 and UbcH7 recovered from 
the Hela cDNA library. 
Open reading frame nucleotide sequence and predicted amino acid sequence of UbcH7 wild type ( wt) 
and UbcH7 missing exon 2 (AE2). UbcH7 (AE2) was identified by Hela cDNA library screening as 
binding to Ad2 EIB 55-kDa. Arrows indicate the positions where the sequence is interrupted by 
introns. Exon 2 is in green. The (*) denotes the stop codon. 
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Figure ?: Purification of UbcH7 and UbcH7.6E2. 
The coding regions of UbcH7 and UbcH7AE2 were generated by PCR. tagged 
with FLAG at the 5' end and 6X His at the 3' end, and cloned into pET22b(+). 
The proteins were exprcssed in E. coli upon IPTG induction and purified using 
Ni-NTA agarose. The proteins were resolved on 12% gel by SDS-PAGE and 
stained with Coomassie brilliant blue (A and B). (A) Purification of UbcH7. Dif-
ferent fractions of elution with 200 mM imidaz:ole are shown. (B) Purification of 
UbcH7AE2. (C) Interaction bctween Ad2 ElB 55-k.Da protein and UbcH7AE2 
assàyed using immunoprccipitation. UbcH7AE2 purified from E. coli and was 
incubated with monoclonal antibody 2A6 against Ad2 ElB 55-kDa (lane 1). or 
with both 2A6 and ElB (lane 2). The precipitates were separated with a 12% gel 
by SDS-PAGE, and the proteins were transferred onto a nitrocellulose membrane 
and detected with monoclonal antibody against the FLAG epitope. Precipitation 
of UbcH7.AE2 requircs the presence of ElB (lane 2), indicating that the two pro-







The C-Terminus of Ad ElB SS-kDa Binds to DAXX in Two-Hybrid Assays 
DAXX was identified as a potential Ad2 ElB 55-k.Da binding partner following 
Hela cDNA library screening. DAXX is a transcription repressor that promotes 
sensitivity to Fas. The C-terminal region of DAXX (aa 621-740) was responsible for Ad 
El B binding. This domain is required for DAXX enhancement of Fas-induced apoptosis, 
localization to PODs, and optimal repression of transcription (Torii et al., 1999). The C-
terminus of DAXX is also involved in interactions with several cellular proteins 
including the main component of PODs, PML (Zhong et al., 2000b ), ETS 1 (Li et al.. 
2000b ), DNA methyltransferase (Michaelson et al., 1999), and CENP-C (Pluta et al., 
1998) . 
The interactions of various Ad El B 55-k.Da deletion mutants fused to the Gal4 
BD, with the C-terminus of DAXX (aa 621-740) fused to the Gal4 AD, were assayed 
using the yeast two-hybrid system. An Ad2 ElB 55-k.Da C-terminal deletion (aa l-437) 
did not bind to DAXX. No growth was seen on plates lacking histidine (figure 8C) or 
adenine (not shown). An Ad2 ElB N-terminal deletion (aa 155-495), along with an Ad2 
ElB C-terminal fragment (aa 437-495), were positive for DAXX interaction and grew on 
plates lacking histidine (figure 8C) and adenine (not shown). 
Ad2 and Ad12 ElB 55-kDa proteins share a high degree of sequence similarity in 
the C-terminal region (aa 153-499). For this reason we tested whether Ad12 ElB could 





Adl2 ElB but not Ad12 ElB C-terminal deletion mutants (aa 1-408 and 1-204) as seen 
in figure 8C. Therefore, the C-terminus of DAXX associates with the C-terminus of both 
Ad2 and Adl2 ElB 55-kDa proteins. 
Ad ElB SS-k.Da Disrupts POO Formation and PML/DAXX Co-Localization 
The pro-apoptotic ability of DAXX is dependent on the physical interaction of 
DAXX with PML and the consequent localization of DAXX into PODs (Torii et al.. 
l 999). The mechanism by which DAXX induces apoptosis from PODs is yet to be 
elucidated but given that DAXX is a transcriptional repressor, one possibility is that 
DAXX represses transcription of genes that promote apoptosis when outside of PODs. 
Ad E 1 B 55-kDa localizes to PODs shortly after viral infection (Doucas et al.. 1996). 
With both Ad E 1 B 55-kDa and PML binding to the same domain of DAXX it is possible 
that the ElB protein prevents PML from interacting with DAXX and thus prevents the 
accumulation of DAXX in PODs. To examine the effect of Ad ElB 55-kDa expression 
on PML/DAXX co-localization, endogenous labeling patterns of PML and DAXX were 
compared in three cell lines: G401, a rhabdoid kidney tumor cell line, G401 CC3, a 
derivative of G401 expressing Adl2 ElB 55-kDa protein, and 293, human embryonic 
kidney cells expressing Ad5 E 1 A and El B pro teins. Cells were fixed and incubated first 
with both mouse anti-PML and rabbit anti-DAXX antibodies followed by labeled 





to Texas red. Localization of these proteins was analyzed by immunofluorescence 
microscopy. 
The localization of PML and DAXX in G401 cells is seen in figure 9A and 98 
respectively. ln these cells both proteins are found in discrete areas in the nucleus. There 
is almost complete co-localization of PML and DAXX in G401 cells as observed by 
merging the images (figure 9C) where co-localization is seen in yellow. This is 
characteristic of the localization of PML and DAXX in PODs (Torii et al., 1999). Panels 
D and E of figure 9 show the localization of PML and DAXX in G401 CC3 cells 
respectively. Due to the presence of Adl2 ElB 55-kDa both proteins go from a punctate 
nuclear staining pattern to a diffuse staining pattern. A few areas of concentrated PML 
localization remain although it was not determined whether or not they correspond to 
PODs. There is no obvious overlap in PML and DAXX labeling as visualized by the 
merged image (figure 9F). Likewise in 293 cells, the presence of Ad5 ElB 55-k.Da leads 
to altered PML and DAXX staining patterns, as seen in figure 9G-1. DAXX is dispersed 
evenly throughout the nucleus white it is difficult to ascertain if PML, although diffused, 
remains in the nucleus. The number of areas of concentrated PML in these cells is less 
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Figure 8: DAXX Interacts with the C-terminus of Ad ElB 55-kDa Proteins. 
Results oftwo-hybrid assays between various Ad ElB 55-kDa constructs and the C-terminus of 
DAXX. A. Representation of Ad2 ElB 55-kDa deletion mutants along with Ad12 ElB full 
length and C-terminal deletion mutants, all fused to the Gal4 DNA-binding domain (BD). B. 
DAXX C-terminus, identified by Hela cDNA library screening as binding to Ad 2 ElB 55-kDa, 
fused to the Gal4 activation domain (AD). C. Co-transformants: Daxx (aa 621-740) fused to 
the Gal4 AD along with (1) Ad2 ElB (aa 1-437), (2) Ad2 ElB (aa 155-495), (3) Ad2 ElB (aa 
437-495), (4) Ad12 ElB (aa 1-204), (5) Ad12 ElB (aa 1-408), (6) full length Ad12 ElB, each 






Figure 9: PML and DAXX localization in cells expressing adenovirus 
E1B55-kDa proteins. 
lmmunofluorescence c0-localization experiments were performed for PML (A, 0, and G) 
and DAXX {B, E, and H) in three cell lines. A, B, and C: G401, a rhabdoid kidney tumor 
cell line. 0, E, and F: G401 CC3, a derivative of G401 expressing Ad12 E1B55-kDa 
protein . G,H,and 1: 293 human embryonic kidney cells expressing Ad5 E1A and E1B 
proteins . Merged images of PML and DAXX: C, F and/. 
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Ad ElB 55-k.Da Affects PML Nuclear Localization 
Endogenous PML localization experiments in cells expressing Ad ElB 55-kDa 
proteins led us to suspect that, apart from the disruption of POD formation, there was an 
effect on PML nuclear expression. To investigate whether PML was appearing in the 
cytoplasm, cell nue lei were stained and the location of PML was examined. G40 1, G40 l 
CC3, and 293 cells were fixed and incubated with mouse anti-PML antibody, followed 
by labeled secondary antibody FITC-conjugated goat anti-mouse. The cells were then 
stained with propidium iodide (Pl) and as a result, nuclei fluoresce red. As seen in panel 
A of figure 10, PML is normally concentrated in PODs in G401 cells. Due to the 
presence of Adl2 or Ad5 ElB 55-kDa proteins (panels Band C of figure 10 respectively) 
the discrete areas of PML expression are replaced by the diffuse staining pattern. Not 
only is the nuclear distribution of PML upset, but also the majority of the PML protein is 
relocalized to the cytoplasm. These single cells are representative of cell populations. 
Comparison of Ad12 EIB 55-k.Da and DAXX Localization in G401 CCJ Cells 
Given the difficulties encountered in immunoprecipitation experiments to verify the 
DAXXIEIB 55-kDa interactions, protein co-localiz.ation was examined in the G401 CC3 
cell line by immunofluorescence microscopy. Primary antibodies used were mouse anti-
DAXX and rabbit alpha-E lB, along with fluorochrome-labeled secondary antibodies, 





figure 11 displays the staining pattern of Adl2 ElB 55-k.Da in green. It is distributed 
throughout the nuclei. DAXX localization in these cells is mainly dispersed (figure 118) 
although a few discrete areas of staining can also be detected. With both proteins found 
throughout the nuclei it is difficult to judge whether or not there is co-localization 
between Adl2 El B 55-kDa and DAXX when the two images are merged (figure l IC) . 
Figure 10: Cellular localization of PML in cells expressing 
Ad ElB 55-kDa proteins. Cells were stained with propidiwn iodide 
and as a result cell nuclei appear red. PML cellular localization was 
examined using anti-PML primary antibody and FITC-labeled secondary 
antibody in G401 cells (A), G401 CC3 cells expressing Ad12 ElB 55-
kDa (a), and 293 cells expressing Ad5 ElA and ElB proteins (C). 
Figure 11: Localization of Ad12 ElB 55-kDa and DAXX in 
G401 CC3 cells. Immunofluorescence staining of FITC-labeled 
Adl2 ElB 55-kDa (A), and Texas Red-labeled DAXX (B). C: merged 




The main goal of this research was to identify cellular targets of the Ad ElB 55-
kDa protein towards elucidating its function. This was accomplished by yeast two-hybrid 
screening of expression libraries with Ad2 ElB 55-kDa as bait. An advantage of the 
yeast two-hybrid method over other protein-protein interaction assays is that detection 
simply involves the growth of yeast colonies on a plate. Thousands of colonies can be 
analyzed each round of yeast co-transfonnation. Partial screening of the expression 
libraries with Ad2 ElB 55-kDa (a total of 1.7 x 106 transformants) revealed 8 yeast and 
11 human proteins positive for ElB-binding (tables 3 and 4 respectively). One of the 
main limitations of the two-hybrid method is that this technique is known to generate 
false positives. Extensive testing eliminated proteins that led to reporter gene activation 
in the absence of the bait (-1500 protêins). The remaining proteins associate specifically 
with Ad2 ElB 55-kDa in the yeast two-hybrid assays but confirmation of these 
interactions requires different experimental approaches. Thus, identified interactions 
must be regarded as putative and be verified by other methods such as 
immunoprecipitation, cross-linking, etc. A second limitation of the two-hybrid method is 
that not ail potential interacting proteins will be stably expressed as fusion proteins in the 
nucleus. Due to lack of expression, improper folding of the fusion, or requirements for 
post-translational modifications, some cellular proteins may be overlooked. There is also 
a fallback to using a cDNA human library to search for ElB-interacting proteins. 
Proteins expressed at high levels that bind to the bait may overwhelm the screen resulting 
in poor representation of proteins that are expressed at low amounts or conditionally 
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expressed. In fact, it does appear that the human proteins identified as interacting 
positively with Ad2 E lB 55-kDa in the two-hybrid screen are normally expressed at high 
levels, although the search was in no way exhaustive. Five of the proteins also came up 
more than once with 17 'hits' representing 11 different proteins. Beyond these 
limitations lies the burden of determining the biological significance of each interaction 
involving the adenovirus bait protein. Protein-interaction studies are useful because they 
provide a starting point. Complete understanding of protein functionality will call for 
information on many levels but yeast two-hybrid library screening has pointed towards 
several prospective avenues of study. Due to time constraints, this project could not 
begin to verify each ElB-protein interaction or explore the implications of each potential 
association. The proteins discovered through library screening will be discussed although 
comments pertaining to the plausibility or possible biological significance of each 
interaction are speculative. 
There are encouraging indicators of the success of the experimental system in 
identifying cellular targets of Ad ElB 55-kDa. First, the Ub-like protein, SUM0-1, 
identified as binding specifically to Ad2 ElB 55-kDa, has been reported recently to 
modify Ad5 ElB 55-kDa in vivo (Endter et al., 2001). Next is the identification of 
proteins from both yeast and human involved in the Ub-proteasome pathway. · Tnese are 
yeast UFDl, involved ata post-ubiquitination step of the Ob-fusion degradation process, 
as well as Ub itself from the Hel.a cDNA library and human UbcH7, a Ub-conjugating 
enzyme. One interaction was confmned in vitro, between Ad2 ElB 55-kDa and 
UbcH7L\E2, by immunoprecipitation (figure 7C). The fact that proteins were singled out 
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more than once from the yeast library, which is constructed from genomic DNA, is also 
significant. RIS 1, Bdf2, and KRI 1 were each identified twice. RIS 1, a member of the 
SWI/SNF2 family of DNA-dependent A TPases (Zhang and Buchman, 1997) shares 
sequence homology with a number of human proteins including DNA-dependent 
ATPases, helicases, repair protein ERCC6, and centrornere protein, CENP-F. Two 
fragments of RIS 1 were picked up during the screen, of 900 bp and 4 kb. Where the two 
fragments overlap there is homology to CENP-F. This suggested that CENP-F might 
interact with Ad2 ElB 55-kDa and CENP-F in fact interacted specifically with the ElB 
bait protein in yeast two-hybrid assays (data not shown). In light of this result it is clear 
that screening a yeast library with the human Ad ElB 55-kDa protein can tell us 
something about possible ElB interactions with human cellular proteins, as originally 
envisioned. Also promising is the identification of possible E 1 B 55-kDa protein targets 
found in the same intranuclear location, discrete subdomains within in the nucleus called 
PODs (Doucas et al., 1996). The E lB-interacting protein DAXX is found in PODs 
(Ishov et al., 1999; Li et al., 2000a), associated with SUM0-1-modified PML (Torii et 
al., 1999). 
As a result of adenovirus infection PODs undergo a dramatic morphological 
change from spherical structures t<? fibrous-like tracks (Doucas et al., 1996). The 
reorganization of PODs may be a consequence of infection. However, several viruses 
express proteins that specifically modify PODs such as herpesviruses: CMV, HSV-1, and 
EBV (Müller and Dejean, 1999; Adamson and Kenney, 2001 ). PODs are disrupted in 
APL linking these nuclear bodies to nonnal cell growth and development (reviewed in 
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Melnick and Licht, 1999). There is also evidence of a rote for PODs in the control of 
gene expression (Zhong et al., 2000c) as suggested by the protein components of these 
structures, including p53, pRb, and CBP. The major component of POOs, PML, is 
induced by type I interferon (Lavau et al., 1995). It is a regulator of major 
histocompatibility complex class I presentation (Zheng et al., 1998) and necessary for 
multiple apoptotic signais (Wang et al., 1998). Taken together it looks as if POOs have 
antiviral potential and dismantling these nuclear bodies is likely a viral strategy to assure 
replication. Overexpression of PML effectively suppresses Ad5 ElA/ElB-mediated 
transformation (Nevels et al., 1999). This suggests that modulation of PML and/or POO 
components plays a role in transformation by adenovirus El gene products. Ooucas et al. 
( 1996) reported that E4orf3 11-kDa was sufficient for POD redistribution in Hep-2 
carcinoma cells. The E4orl3 11-kDa protein, however, does not antagonize the growth 
suppressing activity of PML (Nevels et al., 1999). ElB 55-kDa itself localizes to PODs 
shortly after adenovirus infection, along with E4orf3 (Doucas et al., l 996). To test 
whether the expression of Ad ElB 55-kDa affects POO formation, the intracellular 
localization of PML was examined in three cell lines: G401, a rhabdoid kidney tumor cell 
line, G401 CC3, a derivative of G401 expressing Adl2 ElB 55-kDa protein, and 293, 
human embryonic kidney cells expressing Ad5 ElA and ElB proteins. Figure 9 
illustrates the extensive dispersion of PODs in 0401 CC3 and 293 cells. This indicates 
that Ad ElB 55-kDa proteins are capable of rearranging PODs in the absence ofE4orf3. 
Apart from altered POD formation PI nuclear staining revealed that a fraction of PML 
proteins are relocalized to the cytoplasm as a result of Adl2 ElB 55-kDa expression 





This research on ElB 55-kDa and PODs stemmed from the discovery of a 
potential association with POO component DA.XX from the Hela cDNA library. Yeast 
two-hybrid assays were performed to map the domains responsible for the interaction 
(figure 8). From the results we can conclude that the C-terminal domains of both Ad 2 
El B 55-kDa and E 1 B of highly oncogenic Ad 12 interact with the C-terminus of DA.XX. 
The DAXX/Ad12 ElB 55-kDa interaction could not be verified by immunofluorescence 
microscopy. Protein co-localization was examined in the 0401 CC3 cell line (figure 11). 
With both proteins dispersed throughout the nuclei it is difficult to say whether or not 
there is co-localization between Adl2 ElB 55-kDa and DAXX when the two images are 
merged (figure l lC). Work on this project has been ongoing and it bas been established 
that DAXX and E 18 55-kDa interact in vitro and in vivo (Colosimo et al., in 
preparation). Two distinct regions of DAXX, centered around aa 500-574 and 621-740, 
interact with the El B protein in two-hybrid assays. The identification of a DAXX/ Ad 
E 1 B 55-k.Da interaction has interesting implications for the role of E 1 B in cell 
transformation. DA.XX is thought to mediate Fas ligand-induced apoptosis in response to 
various stimuli (Torii et al., 1999). This introduces a new link between the adenovirus 
oncoprotein and prevention of programmed cell death. 
Torii et al. (1999) showed that the pro-apoptotic activity of DA.XX is dependent 
on a DAXX-PML interaction. Given that ElB could bind the C-terminus of DAXX, a 
region responsible for the association of DA.XX with PML and the localization of DA.XX 
to PODs (Zong et al., 2000b; Torii et al., 1999), the next step was to examine the effects 





immunostaining experiments were performed. Endogenous labeling patterns of PML and 
DAXX were compared in G401, G401 CC3, and 293 cells (figure 9). An altered staining 
pattern is seen for both proteins. PML/DAXX colocalization was disrupted in the 
presence of Ad5/12 ElB 55-kDa proteins. Contrary to the effect that ElB protein 
expression has on PML intracellular localization, DA.XX remains in the nucleus in G40 l 
CC3 and 293 cells. This may be pertinent considering new findings by Ko et al. (200 l) 
that the cytoplasmic localization of DAXX is necessary for Fas-mediated apoptosis. A 
proapoptotic kinase, ASKl, sequestered DAXX in the cytoplasm and inhibited the 
repression of basal transcription by DAXX. 
The combined data implies that another mechanism by which Ad ElB 55-kDa 
contributes to cellular transformation might be by preventing DAXX-induced apoptosis . 
This could ensue from intertèring with PML action on DAXX and/or sequestering 
DAXX in the nucleus. Further studies arising from these results suggest that E 1 B 
inhibits apoptosis by abrogating both PML and p53 regulation of DAXX while enhancing 
DAXX-mediated transrepression (Colosimo et al., in preparation). DAXX acts as a 
potent transcriptional repressor (Hollenbach et al., 1999; Torri et al., 1999). PML 
inhibited transcription repression by DAXX (Li et al., 2000a) but could not do so in the 
presence of ElB 55-kDa. p53 (aa 253-393) was found to interact with DAXX (aa 500-
574). It relieved DAXX-mediated transrepression but, as with PML, not when co-
expressed with ElB 55-kDa. ElB 55-kDa is a powerful transcription repressor (Yew et 
al., 1994) and strengthens the ability ofDAXX to repression transcription. It is known to 





and ElB bind mSin3A and DAXX binds HDACl, therefore the DAXX repression 
complex may be enhanced by the recruitment of additional corepressors and HDACs by 
ElB 55-kDa (Colosimo et al., in preparation). 
Research prospects extending from these results are nurnerous. Regarding 
DAXX, future experiments could test whether E 1 B 55-kDa competes with PML for 
DAXX binding. E 1 B may also interfere with the binding of the C-terminal region of 
DAXX to ETS 1. ETS 1 is one of the cellular genes that make up the transforming protein 
of the E26 virus. When DAXX is bound to ETS 1 it represses ETS 1 dependent 
transactivation of the BCL2 and MMP 1 promoters (Li et al., 2000b ). BCL-2 is an anti-
apoptotic protein while MMP 1 is involved in the process of turnor invasion and 
metastasis. Whether these genes are expressed in G401 CC3 and 293 cells can be 
determined. DAXX also represses Pax3 transcriptional activity (Hollenbach et al., 1999). 
Pax3 is fused to transcription factor FKHR in alveolar rhabdomyosarcoma, a malignant 
turnor of skeletal muscle, as a result of the t(2;13) (q35;ql4) translocation (Shapiro et al., 
1993; Galili et al., 1995). Interestingly, the oncogenic fusion product is no longer 
regulated by DAXX (Hollenbach et al., 1999). It could be tested whether or not ElB 55-
kDa interferes with the regulation of Pax3 by DAXX. A look into what genes are 
regulated by DAXX would give us more information on the significance of the 
DAXX!ElB interaction. Also unknown is the region(s) ofElB 55-kDa required for POO 
dispersal. Various ElB mutants could be expressed in 0401 cells and resulting protein 
localization examined. This might also tell us whether the DAXX/E 1 B interaction was 





condensed chromatin (lshov et al., 1999). It would be interesting to determine if it is 
associated with condensed chromatin in the cell lines expressing E 1 B 55-kDa proteins. 
Aside from DA.XX, library screening bas provided a number of potential E 1 B-interacting 
proteins for consideration. With the exception of Sumo-1 and UbcH7, they remain to be 
confirmed by alternate means. Proteins that look promising and will be discussed here 
include UFDl, UbcH7, Ub, SUM0-1, Bdt2, Clkl, MCM2, and Yap4/6. 
Yeast UFDl, as mentioned above, is involved in the Ub-proteasome pathway, a 
major pathway for the selective turnover of intracellular proteins in eukaryotes, along 
with human UbcH7 and Ub itself. This pathway regulates many cellular processes by 
controlling the levels of key regulatory proteins such as cyclins, histones, oncoproteins 
and tumor suppressors. It is possible that El B itself is targeted for degradation by Ub 
conjugation. The direct interaction between E 1 B 55-kDa and UbcH7 âE2 was verified in 
vitro by immunoprecipitation using purified protein preparations (figure 7C). This 
alternatively spliced version of UbcH7 lacking exon 2 has not been previously described, 
although it may have resulted during construction of the HeLa cDNA library. UbcH7 is 
the Ub-conjugating enzyme required for Ub-mediated degradation of the tumor 
suppressor protein, p53, normally short-lived in cells. The level of p53 in 293 and 040 l 
CC3 cells expressing Ad ElB 55-kDa proteins is markedly increased (data not shown). 
The mechanism by which ElB stabilizes p53 is not known but one mechanism may be by 
interfering with p53 proteolysis through its interaction with UbcH7. Other viral proteins, 
such as the transforming proteins of HPV-16 and HPV-18, enhance Ub-dependent 
degradation of cellular tumor suppressors. E6 associates with p53 (Wemess et al., 1990), 
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white E7 associates with pRb (Boyer et al., 1996), and they target the proteins for 
degradation by the Ub-proteasome pathway. ElB 55-kDa may also interfere with the 
ubiquitination of other proteins requiring UbcH7. It is responsible for Ub-mediated 
degradation of the oncoprotein c-fos (Stancovski et al., l 995) and processing of the NfKB 
precursor p 105 (Orian et al., l 995). NficB targets genes involved in cell growth and 
differentiation, inflammation, lymphocyte activation, and the acute-phase response. A 
human homologue of UFDl, UFDlL, has been described as a potential housekeeping 
gene (Novelli et al., 1998). It will be interesting to discover whether Ad ElB 55-kDa 
interacts with UFDlL. 
Hela cDNA library screening also identified a Ub-like protein, SUM0-1, which 
covalently modifies a limited number of proteins in a manner analogous to ubiquitination 
(Kamitani et al., 1997). SUM0-1 has not been shown to target proteins for degradation; 
instead, this modification affects protein activity and/or intracellular location. Given that 
SUM0-1 was hit upon from screening we thought it possible that E lB itself could be a 
substrate for sumolation. There are other examples of SUM0-1 modification of viral 
proteins: Epstein-Barr virus (EBV) immediate-early protein BZLFl (Adamson and 
Kenney, 2001) as well as cytomegalovirus (CMV) IEl (Müller and Dejean, 1999) and 
1E2 (Hofinann et al., 2000) proteins. ln fact, during the preparation ofthis thesis, Endter 
et al. (2001) published that Ad5 ElB 55-kDa is modified by SUM0-1 in vivo at lysine 
residue 104 (Kl04). This SUM0-1 acceptor site lies within the consensus motif 'PK.xE. 
Sumolation is required for ElB 55-kDa complete transformation by adenovirus and 





ElB protein in track- or dot-like structures that resemble reorganized PODs. There are 
other possibilities that have not been ruled out by the discovery that E 1 B is sumolated. 
For example, binding to SUM0-1 could alter the sumolation status of cellular proteins. 
A decrease in the amount of SUM0-1 modified forms of PML occurs as a result of 
herpes simplex virus (HSV) ICPO and CMV IE 1 expression and this affects POD 
formation (Müller and Dejean, 1999). Along the same lines E 1 B may interfere with 
sumolation of p53. SUM0-1 modification of p53 has been reported to result in an 
increase in p53 transactivation activity (Gostissa et al., 1999; Rodriguez et al., 1999). 
The E4orl3 protein does not interfere with the conjugation of SUM0-1 to PML. There is 
also the possibility that E 1 B binds to SUM0-1 modified proteins through non-covalent 
interaction or that SUM0-1 provides an additional interaction motif for cellular factors . 
Future studies should include investigating the interaction between E 1 B 5 5-kDa 
and Bdf2. Bdf2, functionally redundant with Bdfl, contains two copies of the 
evolutionarily conserved bromodomain, a 110 amino acid module. The bromodomain is 
ubiquitously found in eukaryotes, in proteins implicated in diverse functions. For this 
reason it is difficult to ascertain the utility of this domain. Many bromodomain-
containing proteins participate directly in chromatin modification and transcription 
regulation. Nearly ail of the nuclear HA Ts contain bromodomains, including P/CAF 
(Yang et al., 1996), p300/CBP (Bannister and Kouzarides, 1996; Ogryzko et al., 1996), 
and T AFn250 (Mizzen et al., 1996). Bromodomains interact specifically with acetylated 
lysines of histone H4 (Dhaliuin et al., 1999; Jacobson et al., 2000; Owen et al., 2000; 





binding affinity for H3 and H4 (Pamblanco et al., 2001 ). Given that Bdfl/Bdf2 is 
homologous to the carboxyl-terminal half of mammalian TAF11250 (Matangkasombut et 
al., 2000) it would be important to find out if ElB 55-kDa targets TAFn250 in 
adenovirus-infected cells. By and large, the bromodomain may be a new E 1 B-interacting 
region. E 1 B 5 5-kDa binds to another bromodomain-containing protein, P /CAF (Liu et 
al., 2000). It was not determined whether or not the bromodomain of P/CAF was 
required for the interaction, however, mutant P/CAF missing residues 62 to 464 but with 
an intact bromodomain (aa 722-830) could still bind El B 55-kDa (Liu et al., 2000). This 
interaction prevents P/CAF from binding to p53 thereby inhibiting acetylation of p53 by 
P/CAF (Liu et al., 2000). Interfering with the functions of bromodomain-containing 
proteins may have wide spread consequences. The specific loss of the p300 
bromodomain in the human cervical carcinoma cell line SiHa leads to impairment of 
p300 coactivator function and implicates the bromodomain in tumor suppressor activity 
of p300 (Ohshima et al., 2001 ). Physical interaction with the bromodomain could target 
E 1 B 55-kDa directly to chromatin or chromatin-associated complexes. Considering these 
observations, an important future experiment would be to determine if the bromodomain 
is a newly discovered E 1 B-interacting domain. This would lead to an explosion of data 
on E 1 B 55-kDa and its role in adenovirus-mediated cellular transformation 
Other proteins that it may be interesting to investigate further include cdc2-like 
kinase, Clkl, also termed STY. It was the first dual specificity kinase to be discovered, 
so called because they can phosphorylate both serine/threonine and tyrosine residues 





terminal catalytic domain and an N-terminal functional nuclear localization domain 
(Duncan et al., 1995). The N-terminus also encodes a regulatory domain (Menegay et al., 
2000). Clkl affects the splicing of mRNA as a result of the phosphorylation of SR 
proteins (Duncan et al., 1997; Colwill et al., 1996). lt can regulate its own splicing as 
well as the splicing of Ad ElA pre-mRNA (Duncan et al., 1997). It is possible that this 
kinase is involved in altering the mRNA splicing patterns during the switch from early to 
late phase of adenovirus replication. An interaction with Clkl would implicate ElB 55-
kDa in this process. There is also a mini-chromosome maintenance protein, MCM2. 
MCM2 is required for initiation of DNA replication (Todorov et al., 1994). In all 
eukaryotes MCM proteins 2-7 ensure that DNA replicates only once in each cell cycle 
(for a review on MCM2-7 see Tye, 1999). MCM2 was found to associate with an EBV 
replication origin, oriP along with the human origin recognition complex, ORC, in a cell 
cycle dependent manner (Chaudhuri et al., 2001). An interaction between ElB 55-kDa 
and MCM2 would point towards a possible involvement of these proteins in adenovirus 
DNA replication. Yap4 and Yap6 were found to bind to Ad2 ElB 55-kDa in yeast two-
hybrid assays. Yaps are bZIP proteins reminiscent of human AP- l transcription factors 
(Fernandes et al., 1997). Yaps are related in the coiled coil leucine zipper present in the 
bZIP DNA-binding domain, and in DNA-binding specificity, distinct from AP-l factors. 
Unlike other Yaps, Yap4 and Yap6 share sequence similarity in the leucine zipper. Since 
this domain is present in both fragments obtained by screening perhaps it is targeted by 
the ElB 55-kDa protein. Lastly, the metastasis-associated MTAJ gene encodes a nuclear 
protein product of unknown function. Expression of this gene bas been correlated with 
the metastatic potential of gastrointestinal and breast carcinomas although it is also 
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expressed in many normal tissues (Nawa et al., 2000; Toh et al., 1997). Association with 
MTAl encourages investigation as there is evidence for the involvement ofMTAl in the 
process of cellular proliferation. Inhibition of MT'Af gene expression by antisense 
phosphorothioate oligonucleotides abrogated cell growth of MDA-MB-23 l breast cancer 
cells. Also, the MTAl protein physically associates with HDACl (Toh et al., 2000) and 
thus may be active in chromatin remodeling. Possible ElB 55-kDa effects on MTAl 
would tell us more about the rote MT Al plays in cell proliferation and metastasis. 
The goal of elucidating the rote of the ElB 55-kDa oncoprotein in adenovirus 
transformation is to be able to better understand the progression of cancer and cancer cell 
growth. Human cells become malignant by a multistep process. Prior to neoplastic 
transformation, cells must first become immortalized. Overcoming aging is a critical step 
in malignant tumor formation. Many types of human cells can be immortalized by 
adenovirus oncogenes (Byrd et al., 1982). Compound genetic changes are required to 
induce immortalization. Oncoproteins ofDNA tumorviruses, including Ad ElB 55-kDa, 
SV40 LT, and HPV E6, inactivate p53. The result of p53 inactivation is genomic 
instability leading to additional chromosomal aberrations (reviewed in Shay et al., 1991 ). 
Adenovirus infection is not associated with any known cancers. However, investigating 
the mechanisms of immortalizati~n by adenovirus oncogenes can further our 
understimding of the multistep process of carcinogenesis. Once cells become 
immortalized by adenovirus they are readily made neoplastic by a variety of agents 
(reviewed in Rhim et al., 1990). Although all adenovirus serotypes are capable of 
immortalizing cells in tissue culture, the oncogenic potential of each is different. Highly 
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oncogenic Ad 12 can induce malignant tumor formation in rodents (Trentin et al., 1962). 
To perform the yeast two-hybrid screen we had originally intended to use the E 18 55-
k.Da protein of Adl2. When we experienced problems cloning the construct into the 
pGBDU plasmid we began working with the present bait. When several Adl2 ElB 
deletion mutants were obtained and expressed as Gal4 BD fusion proteins we realized 
that they had negative or detrimental etîects on yeast cell growth to varying degrees. We 
obtained fewer colonies following transformation and these colonies were smaller in size 
than expected. This would make screening the expression libraries an arduous task. 
Many of the potential ElB-binding partners were tested in yeast two-hybrid assays for 
interaction with Ad12 ElB 55-kDa with positive results (figure 8 and data not shown). 
With the focus on ElB-bindin·g proteins involved in cell cycle regulation or apoptosis to 
further investigate Ad El B 55-kDa action in cell transformation, of particular interest 
was the interaction between DAXX and Ad2/12 ElB 55-kDa. Preventing DAXX-
mediated apoptosis may be another mechanism by which the EIB oncoprotein perturbs 
cell growth regulation. Modulation of DAXX and PML functions may be required for 
complete transformation of cells by EIB 55-kDa in cooperation with El A. This research 
has also suggested further possibilities by which Ad ElB 55-kDa inhibits p53 fonction. 
It bas been proposed that ElB 55-kDa may couple a direct transcriptional repressor to 
p53 (Martin and Berk, 1998). Also, EIB 55-kDa specifically inhibits acetylation of p53 
by PCAF (Liu et al., 2000). Disrupting PODs may be one mechanism by which E lB 
prevents p53 activation. The interaction between p53 and PML and the consequent 
targeting of p53 to PODs leads to an increase in p53 transcriptional activity and affects 





interaction suggested by Fogal et al. (2000). This research launched a series of 
experiments that suggest ElB 55-kDa enhances DAXX-mediated transrepression and 
prevents both PML and p53 regulation of DAXX (Colosimo et al., in preparation). Thus 
insight has been gained into the workings of PML oncogenic domain components and 
into relationships between the cellular tumor suppressor proteins, PML and p53, with 
DAXX . 
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• Appendix A - Yeast and Bacteria Media 
Y east Selective Dropout Media 
Ingredients Quantity for 1 L 
Yeast Nitrogen Base (without amino acids) 1.7 g 
Ammonium Sulfate 5.0 g 
Dextrose 20 g 
Amino Acid Solution· 10 ml 
Essential amino acids: Adenine (2 mg/ml) 10 ml 
Histidine (10 mg/ml) 2 ml 
Leucine (l 0 mg/ml) 3 ml 
Lysine ( l 0 mg/ml) 3 ml 
Tryptophane ( l 0 mg/ml) 2 ml 
• Tyrosine (0.75 mg/ml) 40 ml Uracil (2 mg/ml) 10 ml • Any of the 7 essential amino acids can be left out 
• Adjust the pH between 5.0 and 6.0 
• For SD agar add 16.6 g of agar for 1 L 
• Autoclave 
* Amino Acid Solution 
Ingredients Quantity 
Arginine 0.4 g 
Methionine 0.4g 
Isoleucine 0.6 g 
Phenylalanine l g 
Glutamic acid 2g 








Stock Preparation for Essential Amino Acids 
Ingredients Quantity in l OO H20 
Adenine 0.2 g 
Histidine 1.0 g 
Leucine 1.0 g 
Lysine 1.0 g 
Tryptophane 1.0 g (heat) 
Tyrosine 0.075 g (heat) 
Uracil 0.2 g 
• Autoclave 
Bacterial YT Media 
Per liter: 
8 g Bacto-tryptone 
5 g Bacto-yeast extract 




















0 Appendix B - List of Solutions 
De-stain solution 
15% ethanol 
5% acetic acid 
Dialysis buff er 





His binding buffer 
0.5 MNaCl 
20 mM Tris-HCl (pH 7.9) 
20 mM imidazole 
His elution buffer 
0.5 MNaCl 
0 
20 mM Tris-HCl (pH 7.9) 
200 mM imidazole 
His wash buffer 
0.5 MNaCl 
20 mM Tris-HCl (pH 7.9) 
60 mM imidazole 
LETS buffer 
0.01 M Tris-HCl, (pH 8.0) 
0.1 M LiCl 
0.01 MEDTA 




lmM EDTA, (pH 8.0) 
0 
SOS gel-loading buffer 
50 mM Tris-Cl (pH 6.8) 
1 OO mM dithiothreitol 
2%SDS 
0.1 % bromophenol blue 
IO% glycerol 
0.1 M Sodium phosphate buffer CpH 7 .0) 
57.7 mM Na2HP04 
42.3 mM NaH2P04 
Solution 1 
50 mM glucose 






3 M potassium acetate 
11.5% glacial acetic acid 
TAE 
0.04 M Tris-acetate 
0.1 MEDTA 
TE 




50 mM glycine 
20% methanol 
· Tris-glycine electrophoresis buffer 
25 mM Tris 
250 mM glycine 
0.1% SOS 
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Wash buffer 1 





0.02% sodium azide 
W ash buffer 2 





0.02% sodium azide 
0.1% SOS 
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